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Abstract
Deficits within the brain microcirculation contribute to poor patient outcome
following aneurysmal subarachnoid hemorrhage (SAH). However, the underlying
pathophysiology is not well understood. Intra-cerebral (parenchymal) arterioles are
encased by specialized glial processes, called astrocyte endfeet. Ca2+ signals in the
endfeet, driven by the ongoing pattern of neuronal activity, regulate parenchymal
arteriolar diameter and thereby influence local cerebral blood flow. In the healthy brain,
this phenomenon, called neurovascular coupling (NVC), matches focal increases in
neuronal activity with local arteriolar dilation. This ensures adequate delivery of oxygen
and other nutrients to areas of the brain with increased metabolic demand. Recently, we
demonstrated inversion of NVC from vasodilation to vasoconstriction in brain slices
obtained from SAH model animals. This pathological change, which would restrict
blood flow to active brain regions, was accompanied by an increase in the amplitude of
spontaneous Ca2+ events in astrocyte endfeet. It is possible that the emergence of higher
amplitude endfoot Ca2+ events shifts the polarity of NVC after SAH by elevating levels
of vasoactive agents (e.g. K+ ions) within the perivascular space. In the first aim of this
dissertation we tested whether altered endfoot Ca2+ signaling underlies the inversion of
NVC after SAH.
Brain injury is often associated with increased levels of extracellular purine
nucleotides (e.g. ATP). A recent study found that ATP levels in the cerebrospinal fluid
of aneurysmal SAH patients were roughly 400-fold higher than that of non-SAH controls.
Astrocytes express a variety of purinergic (P2) receptors that, when activated, could
trigger a spike in intra-cellular Ca2+. It is possible that enhanced signaling via astrocyte
P2 receptors underlies the change in endfoot Ca2+ signaling after SAH. In the second
aim of this dissertation we determined the role of purinergic signaling in the generation
of high-amplitude spontaneous endfoot Ca2+ events after SAH.
Parenchymal arteriolar diameter and endfoot Ca2+ dynamics were recorded
simultaneously in fluo-4-loaded rat brain slices using combined infrared-differential
interference contrast and multi-photon fluorescence microscopy. We report that SAH led
to a time-dependent emergence of spontaneous endfoot high-amplitude Ca2+ signals
(eHACSs) that were only present in brain slices exhibiting inversion of NVC. Depletion
of intracellular Ca2+ stores abolished spontaneous endfoot Ca2+ signals, including
eHACSs, and restored arteriolar dilation in SAH brain slices to two downstream elements
in the NVC signaling cascade, (1) increased endfoot Ca2+ and (2) elevated extracellular
K+. We next tested the role of purinergic signaling in the generation of SAH-induced
eHACSs by recording endfoot activity before and after treatment with the broadspectrum purinergic receptor antagonist, suramin. Remarkably, suramin selectively
abolished eHACSs and restored vasodilatory NVC in SAH brain slices. Desensitization
of Ca2+-permeable ionotropic purinergic (P2X) receptors had no effect on eHACSs after
SAH. However, eHACSs were selectively blocked using a cocktail of inhibitors
targeting Gq-coupled purinergic (P2Y) receptors. Collectively, our results support a
model in which SAH leads to an emergence of P2Y receptor-mediated eHACSs that
cause inversion of NVC. Further, we identify the FDA-approved drug, suramin, as a
potential therapy to be used in the treatment of aneurysmal SAH.
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Chapter 1: Comprehensive Literature Review
Cerebral Blood Flow
Anatomy of the Cerebral Vasculature
Given its high metabolic demand and extremely limited energy reserves, the brain
is one of the most highly perfused organs in the body. It is continually supplied with
oxygen and nutrients by a dense network of capillaries and micro-vessels which, in
humans, total about 400 miles in length (Begley and Brightman, 2003). In order to reach
these rich capillary beds, oxygenated-blood from the heart is first pumped into the brain
via two pairs of large arteries: the left and right internal carotid arteries, and the left and
right vertebral arteries. The former diverge to become the left and right middle cerebral
arteries (MCAs) and anterior cerebral arteries (ACA), respectively, whereas the latter
converge on the surface of the pons to form the basilar artery. The vertebral-basilar
system feeds the brainstem, cerebellum and posterior portions of the cerebrum.
Collectively, the vertebral-basilar network comprises the posterior circulation of the
brain, whereas the left and right MCAs and ACAs comprise the anterior circulation and
supply the remaining neural tissue.

Although blood flow between the anterior and

posterior circulations is normally kept separate, there is a large anastomosis called the
Circle of Willis located at the ventral surface of the brain which physically links the two
networks.
There are some important differences between the arteries coursing over the brain
surface and their penetrating branches that feed the underlying neurons. Firstly, the walls
of brain surface (pial) arteries are comprised of multiple layers of circumferentially1

oriented vascular smooth muscle cells (Cipolla 2009). Even the smallest pial arteries and
arterioles have from 2-3 layers of vascular smooth muscle. In contrast, penetrating and
parenchymal arterioles have just a single layer of vascular smooth muscle. Another
important contrast is that the walls of pial arteries and arterioles are innervated
extrinsically by the peripheral nervous system (Baeres and Moller 2004; Hamel 2006).
This innervation is lost as the brain-penetrating branches become parenchymal arterioles
deep to the Virchow-Robin space (Cipolla et al., 2004; Cipolla 2009). Accordingly, the
responsiveness of MCA-derived parenchymal arterioles to neurotransmitters such as
serotonin and noradrenaline is significantly blunted when compared to the effects of these
transmitters directly on the MCA (Cipolla et al., 2004). Perhaps the most profound
distinction between pial and parenchymal arterioles is the near complete investment of
parenchymal arterioles by astrocyte endfeet (McCaslin et al., 2011). The endfoot sheath
surrounding parenchymal arterioles plays a very important role in regulating arteriolar
diameter and thus, local cerebral blood flow (Filosa et al., 2015; Kim et al., 2015).
Mechanisms Regulating Cerebral Blood Flow
Continuous perfusion of the brain is essential for the maintenance of neuronal
homeostasis and function. Two key mechanisms are in place to ensure that the brain
remains adequately perfused under a variety of conditions: cerebral auto-regulation and
neurovascular coupling (also known as functional hyperemia). Cerebral auto-regulation
refers to the intrinsic property of the arterial wall to maintain constant blood flow by
responding to increases and decreases in intraluminal pressure by constricting and
dilating, respectively.

This remarkable property, called myogenic tone, was first
2

described over a hundred years ago by the English physiologist, William Bayliss
(Bayliss, 1902), and the mechanisms by which this occurs in the brain have only recently
begun to be elucidated. Currently, the prevailing theory is that pressure-induced stretch
activates G-coupled purinergic receptors (in the case of parenchymal arterioles) on the
smooth muscle membrane leading to Na+ influx via transient receptor potential melastatin
4 (TRPM4) channels (Brayden et al., 2013; Li et al., 2014). The activation of TRPM4
causes smooth muscle depolarization, Ca2+ influx through voltage-dependent Ca2+
channels (VDCCs) and activation of the contractile apparatus.

This cerebral auto-

regulatory mechanism ensures constant blood flow over a range of physiologic pressures
and also serves to protect downstream capillaries from drastic changes in blood flow
which would occur in the absence of myogenic tone.
Aside from cerebral auto-regulation, the brain possesses the unique ability to
redirect blood flow according to ongoing changes in neuronal metabolic demand.
Interestingly, this process, called neurovascular coupling, was first noted by Roy and
Sherrington (1890) well before the auto-regulatory phenomenon had been observed. In
their classic study, Roy and Sherrington (1890) measured volume expansion of the canine
brain during peripheral nerve stimulation, and reported that brief stimulation of the sciatic
nerve reliably evoked an immediate increase in cerebral volume.

This transient

expansion of the brain paralleled a rise in arterial pressure suggesting that increased
neuronal activity was tightly coupled to increased cerebral blood flow. Notably, the
evoked cerebral volume expansion was observed under a variety of conditions including
stimulation of the medulla oblongata and spinal cord.

It was even evident during

volitional movement of the lightly anesthetized animal. Although this rudimentary study
3

was unable to address the mechanistic pathway involved, it succeeded in advancing the
notion that neuronal activity and cerebral blood flow are functionally linked.
Importantly, this study helped lay the groundwork for a concept (i.e. neurovascular
coupling) which would later form the basis of functional magnetic resonance imaging
(fMRI).
Astrocytes and their Relationship to Intra-Cerebral Blood Vessels
Investment of local synapses as well as the intra-cerebral vasculature by cortical
astrocytes was first described over a century ago by the renowned neuroanatomist,
Santiago Ramon y Cajal (Navaerrete and Araque, 2014). This structural arrangement
between astrocyte endfeet and nearby blood vessels has since been confirmed using more
conventional methods, such as transmission electron microscopy and in vivo multiphoton imaging (Mathiisen et al., 2010; McCaslen et al., 2011). Interestingly, early
analyses of astrocyte biophysical properties suggested that the functional significance of
this arrangement served to protect neuronal elements by shunting the increase in
extracellular K+ ions that accompanies enhanced synaptic transmission to distant areas
with lower K+ levels (Trachtenburg and Pollen, 1970). Later work by Newman (1984)
expanded on this theme by demonstrating substantial K+ conductance in astrocyte endfeet
which could be stimulated by an elevation of extracellular K+ at distal cellular processes.
Remarkably, the evoked K+ conductance exhibited by the endfeet was roughly 10-fold
higher than that of the rest of the cell (Newman, 1986). These observations ultimately
led the investigators to pose the question of whether the K+ released from astrocyte

4

endfeet in response to enhanced neurotransmission plays a role in the regulation of local
cerebral blood flow (Paulson and Newman, 1987).
Unfortunately, however, this concept was ahead of its time. Before the matter
was directly addressed in the study by Filosa et al. (2006) a number of important
observations were made which helped bolster our understanding of the signaling
dynamics between neurons and astrocytes. The first major discovery was that of intraand inter-cellular Ca2+ waves in cultured astrocyte networks exposed to the excitatory
neurotransmitter, glutamate (Cornell-Bell et al., 1990). The observation that glutamate
evoked astrocyte Ca2+ waves that often spread between cells, was the first indication that
local synaptic activity could elicit long-range signaling in nearby astrocytes. Importantly,
this concept was confirmed by subsequent work demonstrating similar Ca2+ elevations in
hippocampal astrocytes in situ following brief stimulation of the Schaffer collaterals
(Porter and McCarthy, 1996); the principle excitatory input to the hippocampus. The
elevation of astrocyte Ca2+ in these studies was suggested to be due to spillover of
glutamate from the synaptic cleft activating ionotropic and metabotropic glutamate
receptors on astrocyte processes. This possibility was supported by the later work of
Shelton and McCarthy (1999) who showed that astrocyte Ca2+ elevations could be
evoked by treating brain slices with the group I/II metabotropic glutamate receptor
agonist, t-ACPD.
Astrocyte Involvement in Neurovascular Coupling
Considering the anatomical arrangement of astrocytes, with some processes
enveloping neuronal synapses and others wrapping around the intra-cerebral vasculature
5

(i.e. endfeet), it was only natural to ask whether a link existed between neuronal activityevoked astrocyte Ca2+ elevations and the regulation of local cerebral blood flow. Taking
advantage of the ex vivo brain slice preparation, which preserves the unique architecture
of astrocytes, Zonta et al (2002) clearly demonstrated that neuronal stimulation triggered
astrocyte endfoot Ca2+ elevations which preceded vasodilation of the underlying arteriole.
Further, consistent with previous studies, treatment of brain slices with a metabotropic
glutamate receptor antagonist, MPEP, significantly blunted the neurally-evoked endfoot
Ca2+ elevations as well as arteriolar dilation. Conversely, application of the metabotropic
glutamate receptor agonist, t-ACPD, triggered a rise in endfoot Ca2+ that preceded
arteriolar dilation. Expanding on this work, Winship et al. (2007) confirmed these results
in vivo by demonstrating rapid, neuronal activity-dependent Ca2+ signals in cortical
astrocytes which preceded the hyperemic response. Together, these studies comprised
the first demonstration of an essential role for astrocyte Ca2+ signaling in linking neuronal
activity with increased local cerebral blood flow. However, it should be noted that in the
decades prior to these studies, the prevailing theory behind neurovascular coupling was
that direct innervation of the vascular wall contributed to the coordination of local blood
flow with neuronal function (Reinhard et al., 1979; Vaucher and Hamel, 1995; Krimer et
al., 1998). While this theory has lost support over the years, the existence of a neuronal
component to neurovascular coupling cannot be totally ruled out.
To this day there is dissention as to the vasoactive factor(s) that are released from
the endfeet during neurovascular coupling. Generally speaking, there are 2 major Ca2+dependent pathways which could be recruited in the endfeet following neuronal
activation (Fig. 1).

The first of these pathways, which gained popularity early on,
6

involves Ca2+-dependent cleavage of arachidonic acid (AA) from the endfoot membrane
by phospholipase A2 (PLA2) (Koehler et al, 2009). Early work using primary cultures of
astrocytes obtained from 3-day-old rat pups showed that exposure to glutamate mobilized
AA and resulted in the release of one of its metabolites, epoxyeicostrienoic acids (EETS)
(Alkayed et al., 1997). EETs are potent dilators of brain surface arteries and exert their
effect by enhancing K+ efflux from vascular smooth muscle cells (Gebremedhin et al.,
1992). Formation of EETs from AA requires the action of cytochrome P-450 (P-450)
2C11, an enzyme which has been shown to be expressed by cortical astrocytes (Alkayed
et al., 1996). Interestingly, treatment of pial arteries with another AA metabolite, 20hydroxyeicosatetraenoic acid (20-HETE), caused vasoconstriction by inhibiting smooth
muscle K+ channel activity (Harder et al., 1994). Contrary to EETs, the generation of 20HETE from AA occurs via the action of P-450 4-A. Harder et al (1994) demonstrated
functional expression of P-450 4-A in cerebral vascular smooth muscle cells isolated
from cats.

In a perplexing, yet high-profile study by Mulligan and MacVicar (2004),

elevation of astrocyte endfoot Ca2 by photolysis of caged-Ca2+ (uncaging) caused
vasoconstriction of the underlying blood vessel. Based on their pharmacologic approach,
the investigators concluded that the endfoot Ca2+ elevation activated Ca2+-sensitive PLA2
leading to the release of AA from the endfoot membrane. According to their model, the
liberated AA then diffused across the perivascular space entering the vascular wall where
it was metabolized into the vasoconstrictor, 20-HETE, by P-450 4-A. It is important here
to mention that the brain slices used in these studies were not pretreated with a
vasoconstrictive agent. Thus, as the vasculature in their preparation was unpressurized, it
7

is likely that the vessels were maximally dilated at baseline. This complicates things, as
the only response that could be measured, based on their conditions, is vasoconstriction.
There is yet a third class of vasoactive AA metabolites which has been suggested
to play a role in neurovascular coupling; the prostaglandins (Haydon and Carmignoto
2006). In a study by Zonta et al (2003) it was discovered that the glutamate-induced
elevation of intracellular Ca2+ elevation led to the release of prostaglandin E2 (PGE2)
from astrocytes in vitro. Astrocytes express the cyclooxygenase-2 (COX-2) enzyme
which is responsible for the conversion of AA to PGE2 (Hirst et al., 1999). Interestingly,
despite the attention and recognition PGE2 has received for its alleged vasodilatory
influence during neurovascular coupling (Attwell et al., 2010), recent work demonstrated
that PGE2 actually constricts parenchymal arterioles isolated from the rodent brain
(Dabertrand et al., 2013). This would argue against the involvement of astrocyte-derived
PGE2 in linking neuronal activity to increased local cerebral blood flow.
Given the confounding results and complex mechanism(s) by which astrocytederived AA is thought to impact the local intra-cerebral vasculature during neurovascular
coupling, it is difficult to reconcile this pathway with the rapid and highly reproducible
vasodilatory responses exhibited by parenchymal arterioles in vivo (Winship et al., 2007).
The second Ca2+-dependent pathway which could be recruited into neurovascular
coupling brings us back to the original proposition by Paulson and Newman (1987). That
is, astrocyte-mediated K+ release establishes the link between increased neuronal activity
and enhanced local cerebral blood flow. Cerebral arteries are extremely sensitive to
changes in the extracellular K+ concentration. Modest increases in extracellular K+ (≤ 20
mM) dilate cerebral arteries and parenchymal arterioles by activating inward rectifier K+
8

(Kir) channels on vascular smooth muscle (Knot et al., 1996; Zaritsky et al., 2000; Filosa
et al., 2006; Girouard et al., 2010). Conversely, larger increases in extracellular K+ (> 20
mM) depolarize the smooth muscle membrane leading to enhanced Ca2+ influx through
VDCCs and vasoconstriction. Large-conductance Ca2+-activated K+ (BK) channels are
enriched in the endfoot membrane abutting parenchymal arteriolar smooth muscle (Price
et al., 2002). Astrocytes express the β4 subunit which confers profound Ca2+ sensitivity
to the BK channels (Horrigan and Aldrich, 2002; Bai et al., 2011; Seidel et al., 2011). As
parenchymal arteriolar dilation occurs within seconds of an evoked rise in endfoot Ca2+
(Takano et al., 2006), Filosa et al. (2006), tested whether endfoot BK channels are
recruited into the neurovascular coupling signaling cascade. Using on-cell patch clamp
electrophysiology, Filosa et al. (2006) clearly demonstrated robust iberiotoxin-sensitive
BK currents in the endfeet following neuronal activation. Thus, during neurovascular
coupling, BK-dependent K+ efflux could conceivably impact blood vessel diameter by
directly affecting the smooth muscle membrane potential. This would be consistent with
the rapid responses of parenchymal arterioles (1-2 second latency) to increased endfoot
Ca2+ (Takano et al., 2006).
Elevation of extracellular K+ can cause either dilation or constriction depending
on the concentration (Knot el al., 1996). In a clever study demonstrating the duality of
arteriolar responses to elevated K+, Girouard et al. (2010) showed that evoking a modest
rise in endfoot Ca2+ (300-400 nM) caused the anticipated vasodilation, whereas evoking
larger increases in endfoot Ca2+ (> 700 nM) caused vasoconstriction. Interestingly,
Girouard et al (2010) also showed that arteriolar constriction could be evoked by raising
endfoot Ca2+ modestly (300-400 nM) in the presence of artificially elevated extracellular
9

K+ .

Importantly, both the evoked dilations and constrictions were abolished in the

presence of the BK channel blocker, paxilline. These data not only highlight endfootderived K+ as a key mediator of neurovascular coupling, they also show that polarity of
the arteriolar response depends on the amount of K+ released (i.e. the amplitude of the
endfoot Ca2+ transient).
At present, the pathways involved in neurovascular coupling are still under
scrutiny. For example, the identity of the vasoactive agent released from the endfeet
during neurovascular coupling continues to be debated. Further, recent advances in
genetic manipulation techniques (e.g. knock-outs and designer receptors exclusively
activated by designer drugs [DREADS]) have shaken the field and questioned the role of
astrocyte Ca2+ signaling in mediating neurovascular coupling (Nizar et al., 2013; Bonder
and McCarthy, 2014). Despite these setbacks, however, it seems that even in a mouse
model in which astrocytes allegedly lack inositol 1,4,5-trisphosphate (IP3) dependent
Ca2+ signals, both endfoot Ca2+ signaling and neurovascular coupling are retained
(Srinivasan et al., 2015). Currently, the field of neurovascular coupling is also even
beginning to explore the potential role of the vascular endothelium in mediating the
upstream arteriolar dilation (Chen et al., 2014).

It is possible that endothelial Kir

channels sense ongoing changes in local K+ and send a hyperpolarizing electrical signal
through the capillary network to dilate upstream arterioles (Longden and Nelson, 2015).
Importantly, it is likely that for such a critical phenomenon as neurovascular coupling,
there will be multiple, redundant pathways to ensure adequate delivery of oxygen-rich
blood to areas of the brain with increased metabolic demand.
10

Stroke
Definition and Classifications
Strokes, often referred to as cerebrovascular accidents, occur following a
pathological disruption of blood flow to the brain that results in neuronal cell death.
Broadly, strokes are classified into two subtypes: ischemic and hemorrhagic. In the case
of ischemic strokes, blood flow to the brain, or parts of the brain, is disrupted by a
physical barrier, often a blood clot. Ischemic strokes are the most common form of
stroke and recent work has actually demonstrated a reduction in age-standardized
mortality rates over the past two decades for ischemic stroke patients (Bennett et al.,
2009). Conversely, hemorrhagic strokes, which include both intra-cerebral hemorrhage
(ICH) and subarachnoid hemorrhage (SAH), are much less prevalent (~ 10-27% of all
strokes) yet both have 30-day mortality rates at nearly 50% (Feigin et al., 2009;
Krishnamurthi et al., 2014).
Hemorrhagic strokes, as the name implies, involve massive bleeding following
the rupture of a cerebral blood vessel.

This bleeding can occur within the brain

parenchyma, in the case of ICH, or within the subarachnoid space, as in SAH. For the
purposes of this dissertation, we will focus primarily on SAH.
Aneurysmal Subarachnoid Hemorrhage (SAH)
The rupture of a “saccular” cerebral aneurysm, an acquired vascular abnormality
causing protrusion of the arterial wall, accounts for 80-85% of spontaneous, nontraumatic SAH strokes (Jakubowski and Kendall, 1978). Cerebral aneurysms typically
form at the base of the brain near branch points close to the Circle of Willis (Ajiboye et
11

al., 2015). The incidence of cerebral aneurysms in adults is estimated between 1-5%
(Mocco et al., 2004), yet aneurysm rupture is quite rare; affecting only about 30,000
people annually in the United States (Peters et al., 2001). Following aneurysmal rupture,
high-pressure arterial blood is released into the subarachnoid space (i.e. SAH) where it
can spread over the brain surface. As mentioned, this form of stroke carries a relatively
high mortality rate and only about half of long-term survivors regain independence for
daily life (Passier et al., 2012).
A major hurdle affecting survival and functional outcome after aneurysmal SAH
is the development of delayed cerebral ischemia (DCI) days to weeks after the initial
bleed (Al-Khindi et al., 2010; Ostergaard et al., 2013). DCI presents either as cerebral
infarction within a single territory close to the site of aneurysm rupture, multiple
independent lesions scattered throughout the brain, or a combination of both (Dreier et
al., 2002; Rabinstein et al., 2005; Weidauer et al., 2008). Historically, the prolonged,
blood-induced constriction of large-diameter pial arteries (i.e. vasospasm) was thought to
underlie the development of DCI after SAH (Pluta et al., 2009). This is largely because
the development of SAH-induced vasospasm, occurring 3-8 days post-stroke, often
coincides with the onset of DCI (Weir et al., 1978). However, recent clinical trials using
the endothelin receptor inhibitor, Clazosentan, have demonstrated effective prevention of
vasospasm, yet failed to significantly improve patient outcome (Macdonald et al., 2011;
Macdonald et al., 2012). Importantly, this indicates that vasospasm is not the sole cause
of DCI after SAH. Further, these negative results have redirected the focus of SAH
research to other mechanisms that could conceivably play a role in the development of
DCI.
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Impact of SAH on the Intra-Cerebral Vasculature
Currently, the prevailing theory is that a disruption of blood flow within the brain
parenchyma after SAH contributes to the development of DCI by restricting O2 delivery
to discrete brain territories. This idea is attractive; as it is consistent with the fact that
angiographic vasospasm often fails to predict the pattern of subsequent brain infarction in
SAH patients (Rabinstein et al., 2005; Weidauer et al., 2008). Further, the arterial
networks on the brain surface exhibit substantial anastomoses and redundancy which are
protective in case of small vessel occlusion (Vander Eecken and Adams, 1953). In
contrast, parenchymal arterioles lack such collateral flow (Nishimura et al., 2010). Each
arteriole feeds a specific domain within the cortex and there is little overlap in the
territories supplied by neighboring vessels. Thus, disruption of blood flow through one
or more adjacent parenchymal arterioles would be predicted to cause a spatially-defined
focal infarct, similar to what is observed in the human brain following SAH (Dreier et al.,
2002; Rabinstein et al., 2005; Weidauer et al., 2008).
The idea that blood flow through distal arterioles (in relation to brain surface
arteries) is hemodynamically important after SAH is not necessarily new. Descriptions
of this concept can be found in early reports of altered cerebral blood flow almost 50
years ago (Zingesser et al., 1968; Heilbrun et al., 1972). Heilbrun et al. (1972) even
suggested that auto-regulatory dysfunction in the small-diameter arterioles could lead to
focal ischemia after SAH by reducing blood flow beyond some critical threshold.
Interestingly, more recent work implicates impairment in metabolically-driven changes in
intra-cerebral blood flow (i.e. functional hyperemia, or neurovascular coupling) in
aneurysmal SAH patients (Dreier et al., 2009).
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In this study, the investigators

simultaneously measured brain electrical activity and regional cerebral blood flow using
direct current-electrocorticography and laser Doppler flowmetry, respectively.

The

authors found that cortical spreading depolarizations (CSDs), which involve a mass
neuronal depolarization followed by a quiescent recovery period, were sometimes
accompanied by a physiologic hemodynamic response (i.e. increased blood flow and
tissue hyperoxia) or an inverse hemodynamic response (decreased blood flow and tissue
hypoxia). Importantly, clusters of prolonged CSDs, which were associated with inverse
hemodynamic responses, occurred in regions exhibiting neuronal damage. These data
indicate a possible link between inverse hemodynamic responses (i.e. neuronal activitydependent vasoconstriction) and the development of focal brain injury in patients
following aneurysmal SAH.
Animal Models to Understand SAH Pathology
Understanding the impact of SAH on intra-cerebral hemodynamics is difficult
given the technical limitations for human studies. However, the use of animal models has
provided a great advantage in our ability to discern the mechanisms leading to vascular
dysfunction and the development of DCI following SAH. The breadth of animal models
ranges from rodents to non-human primates. For the purposes of this dissertation, we
will focus primarily on the rat intra-cisternal double injection SAH model. Although this
model has been modified from the original (Solomon et al., 1985) by including a second
SAH induction (usually following a 24-48 hour recovery period), it is frequently used as
it reliably recapitulates the delayed vasospasm observed in SAH patients (Vatter et al.,
2006). Briefly, autologous arterial blood is introduced into the subarachnoid space of
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anesthetized animals by way of the cisterna magna. Typically, the animals are then
allowed to recover for 24 to 48 hours, after which the procedure is repeated. One
limitation is that this model does not mimic the arterial wall damage accompanying a
ruptured aneurysm. However, it is still preferred over vascular perforation models as the
blood volume entering the subarachnoid space is under the experimenter’s control.
Using experimental models of SAH, such as the ones described above, we now
know that the presence of subarachnoid blood has a profound impact on parenchymal
arteriolar function. Ex vivo studies using animal models of SAH have demonstrated
enhanced myogenic tone and decreased sensitivity to endothelial-derived vasodilators in
isolated parenchymal arterioles (Park et al., 2009; Nystoriak et al., 2011). Given that
brain parenchymal arterioles account for roughly 40% of the total cerebrovascular
resistance (Faraci and Heistad, 1990), the enhanced tone in these blood vessels after SAH
could significantly limit cerebral perfusion on a global scale. This interpretation would
be consistent with the early observations by Heilbrun et al. (1972), who noted a decrease
in global cerebral blood flow in SAH patients even in the absence of angiographic
vasospasm.
It is possible that extravasated blood components, such as oxyhemoglobin, could
cause enhanced tone after SAH by altering expression of key ion channels on
parenchymal arteriolar myocytes. Acute exposure of pial arteries to oxyhemoglobin led
to enhanced pressure-dependent constriction by suppressing voltage-dependent K+ (Kv)
channels on vascular smooth muscle (Ishiguro et al., 2006). Further, culturing pial
arteries for five days in the presence of the blood component, oxyhemoglobin, resulted in
functional expression of the R-type VDCC (Link et al., 2008). Importantly, upregulation
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of the R-type VDCC contributed to the myogenic tone of these arteries. Although the
studies above addressed SAH-induced changes in brain surface arteries, they have helped
pave the way for elucidating the impact of SAH on parenchymal arterioles. Accordingly,
studies have shown that parenchymal arteriolar myocytes isolated from SAH model
animals exhibit suppression of Kv channels (Koide and Wellman, 2013). Importantly, Kv
suppression in parenchymal arterioles appears to involve the same oxyhemoglobinmediated endocytic pathway causing Kv suppression in pial artery myocytes (Koide et al.,
2007). To date, however, it remains to be determined whether parenchymal arteriolar
myocytes express R-type VDCCs after SAH.
The above mechanisms, which affect parenchymal arteriolar auto-regulation,
would be expected to negatively impact blood flow in the brain on a global level by
increasing the total cerebrovascular resistance. However, as mentioned previously, blood
flow through parenchymal arterioles is also regulated extrinsically by surrounding
astrocyte endfeet in a phenomenon called, neurovascular coupling. Human studies have
already provided evidence demonstrating an inverse coupling between neuronal activity
and local cerebral blood flow after SAH (Dreier et al., 2009). Importantly, this deficit is
also present in the rat double injection SAH model. Recent work demonstrated inversion
of neurovascular coupling from vasodilation to vasoconstriction in brain slices obtained
from SAH model animals (Koide et al., 2012). As mentioned, neurovascular coupling is
dependent on neurally-evoked elevation of endfoot Ca2+ causing release of vasoactive
agents (such as K+ ions) into the perivascular space (Straub and Nelson, 2007).
Importantly, Koide et al. (2012) demonstrated that the opposing vascular responses
between control and SAH animals (i.e. dilation and constriction) were both abrogated in
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the presence of the BK channel blocker, paxilline.

This suggests that elevation of

extracellular K+ mediates both the dilation in control animals and the constriction after
SAH. Further, this study demonstrated that the dilation and constriction were retained
even when endfoot Ca2+ was elevated experimentally by photolysis of caged-Ca2+; a
technique that bypasses neuronal activation.

This indicates that the inversion of

neurovascular coupling after SAH reflects abnormal signaling between the astrocyte
endfeet and underlying parenchymal arterioles.
The investigators made another interesting observation in this study; an increase
in the amplitude of spontaneous Ca2+ events in astrocyte endfeet surrounding
parenchymal arterioles. Importantly, the increased amplitude of spontaneous Ca2+ events
after SAH was suggested to cause an abnormal elevation of perivascular K+ that, when
combined with K+ efflux stimulated by neuronal activity or endfoot Ca2+ uncaging, raised
perivascular K+ beyond the dilation/constriction threshold (Fig. 2). This interpretation
would be consistent with previous work by Girouard et al. (2010) which showed that
artificially raising the pre-existing K+ concentration resulted in a reversal of
neurovascular coupling from vasodilation to vasoconstriction in brain slices from healthy
control animals.

Further, this interpretation is significant because the concept of a

functional change in astrocytes leading to a vascular deficit after SAH had not been
previously considered. Determining the role of spontaneous astrocyte Ca2+ signaling in
mediating a disturbance in local cerebral blood flow will profoundly impact our
understanding of the adverse events following SAH. The first aim of this dissertation is
to determine whether altered Ca2+ signaling in astrocyte endfeet underlies SAH-induced
inversion of neurovascular coupling.
17

Astrocyte Ca2+ signaling
Evoked vs Spontaneous Ca2+ Signaling
Astrocytes are incapable of firing action potentials, but rather, they signal to
neighboring cells using a special form of Ca2+ excitability (Verkhratsky et al., 1998).
Astrocyte Ca2+ signaling can be triggered by a variety of manipulations including:
exposure to endogenous ligands (e.g. glutamate, histamine, and ATP) (Cornell-Bell et al.,
1990; Kirischuk et al., 1995; Shelton and McCarthy, 2000), electrical stimulation
(Nedergaard, 1994), and mechanical stretch (Newman and Zahs, 1997).

The

responsiveness of astrocytes to these environmental signals highlights their role in
sensing and maintaining CNS homeostasis.
Shortly after the discovery that neurotransmitters such as glutamate evoke
astrocyte Ca2+ elevations (Cornell-Bell et al., 1990), it was discovered that astrocytes in
culture exhibit spontaneous fluctuations in intra-cellular Ca2+ in the absence of neuronal
input (Fatatis and Russell, 1992).

This early work sparked considerable interest in

determining the nature and functional consequences of spontaneous astrocyte Ca2+
signaling. In their now classic study, Parri et al. (2001) first proposed the concept that
astrocytes not only sense ongoing neurotransmission, but that they can also act as
generators of neuronal activity through spontaneous fluctuations in intracellular Ca2+. By
combining patch clamp electrophysiology with brain slice Ca2+ imaging, the investigators
demonstrated that asynchronous, spontaneous (i.e. non-stimulated) intra- and intercellular astrocyte Ca2+ waves triggered NMDA receptor-mediated currents in adjacent
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neurons. A similar approach by Fiacco and McCarthy (2004) demonstrated astrocyte
Ca2+ signal-dependent AMPA receptor currents in adjacent neurons. These thoughtprovoking studies sparked a massive interest in linking spontaneous astrocyte Ca2+
signaling to neuronal physiology. As a result, we now know that astrocyte spontaneous
Ca2+ signaling contributes to synaptic plasticity (Henneberger et al. 2010; Navarrete et
al., 2012; Chen et al., 2013), neurotransmitter release (Perea and Araque, 2007), and
network activity (Angulo et al., 2004). Further, it is likely that the same astrocyte-toneuron signaling pathways, which were largely explored in rodent brains, are relevant to
the human condition. Using biopsies from human epileptic patients, Navarrete et al.
(2013) showed convincing evidence that astrocyte Ca2+ signals could increase the
frequency of NMDA receptor-mediated currents in neighboring cortical or hippocampal
neurons.
While the bulk of the work has examined spontaneous Ca2+ signaling in astrocyte
somata or perisynaptic processes, it should be noted that astrocyte endfeet also exhibit
spontaneous Ca2+ events in the absence of neuronal stimulation (Koide et al., 2012; Dunn
et al., 2013; Shigetomi et al., 2013).

Currently, there is little known about these

spontaneous endfoot Ca2+ oscillations.

However, it is possible that endfoot Ca2+

signaling could influence neurovascular coupling by altering levels of vasoactive
substances (e.g. K+ ions) within the restricted perivascular space, as was suggested to
occur following SAH (Koide et al., 2012).
Ca2+-permeable TRP Vanilloid 4 (TRPV4) channels are functionally expressed on
astrocyte endfeet (Benfenati et al., 2007).

Dunn et al. (2013) demonstrated that

pharmacologic activation of endfoot TRPV4 channels resulted in a transient increase in
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the frequency and amplitude of spontaneous endfoot Ca2+ events in situ. Interestingly,
pharmacologic inhibition of endfoot TRPV4 activity abrogated neurovascular coupling
responses (both endfoot Ca2+ elevation and arteriolar dilation) in situ and in vivo. These
data suggest a possible role for endfoot TRPV4 channels during neurovascular coupling
in healthy control animals. To determine whether aberrant TRPV4 activity contributed to
the increased amplitude of spontaneous endfoot Ca2+ events and inversion of
neurovascular coupling after experimental SAH, Koide and Wellman (2015) recorded
these phenomena in brain slices obtained from SAH animals before and after treatment
with a selective TRPV4 inhibitor. The investigators found no effect of TRPV4 inhibition
on the altered Ca2+ signals or inverted neurovascular coupling responses after SAH.
To date, the studies by Dunn et al. (2013) and Koide and Wellman (2015)
represent the only attempts to elucidate the role of spontaneous endfoot Ca2+ signaling on
local blood flow regulation in brain cortex. Thus, determining whether the increased
amplitude of spontaneous endfoot Ca2+ events drives inversion of neurovascular coupling
after SAH will not only resolve a potential pathway involved in SAH pathology, it may
also identify another role for endogenous astrocyte Ca2+ signaling in the brain.
Origin of Spontaneous Ca2+ Signals in Astrocytes
Astrocyte Ca2+ signals, whether evoked or spontaneous, are generally appreciated
to result from the release of Ca2+ from subcellular IP3-dependent ER stores (Cornell-Bell
et al., 1990; Shao and McCarthy, 1995; Nett et al., 2002; Parri and Crunelli, 2003; Straub
et al., 2006).

Astrocytes express a multitude of Ca2+-permeable ion channels (e.g.

TRPV4) and Gq-coupled receptors that, when activated, could trigger Ca2+ release from
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the ER. Early studies examining spontaneous astrocyte Ca2+ signaling in the developing
ventrobasal thalamus attributed a Ca2+-induced Ca2+ release (CICR) pathway involving
Ca2+ influx through voltage-dependent Ca2+ channels (VDCCs) triggering subsequent
Ca2+ release through subcellular IP3 receptors (IP3Rs) (Parri et al., 2001; Parri and
Crunelli, 2003).

However, the expression of VDCCs in astrocytes is controversial.

Currently, the only evidence for VDCC expression in astrocytes comes from studies
examining cultured cells (MacVicar, 1984; MacVicar et al., 1991; Latour et al., 2003).
Aside from the few studies examining astrocytes of the developing thalamus (Parri et al.,
2001; Parri and Crunelli, 2003), there is no evidence of VDCCs in hippocampal or
cortical astrocytes in situ (Carmignoto et al., 1998). It is possible that VDCC expression
in astrocytes is location-specific and/or developmentally regulated. We learned earlier
that activation of TRPV4 channels could transiently increase the amplitude and frequency
of spontaneous endfoot Ca2+ events (Dunn et al., 2013). This effect was mediated by
CICR in the endfeet. However, inhibition of TRPV4 channels did not block the basal
events suggesting that spontaneous endfoot Ca2+ activity occurs independent of TRPV4
channels.
A thorough characterization of the mechanism underlying the generation of
spontaneous astrocyte Ca2+ signals was provided in an early study by Nett et al. (2002).
These investigators ruled out the possibility that basal neuronal activity contributed to the
generation of astrocyte Ca2+ events by recording astrocyte Ca2+ activity in the presence of
tetrodotoxin (TTX) or Bafilomycin A1. TTX blocks the generation of neuronal action
potentials by inhibiting fast Na+ channels on neurons. Bafilomycin prevents the filling of
synaptic vesicles with neurotransmitter by inhibiting the vacuolar H+-ATPase pump
21

(Zhou et al., 2000). In both cases, spontaneous astrocyte Ca2+ signals persisted in the
absence of neurotransmitter release arguing against a role for neuronal input in the
generation of astrocyte Ca2+ signals. To examine the possibility that ambient levels of
extracellular glutamate or ATP could trigger these apparently endogenous glial Ca2+
signals, Nett et al. (2002) recorded astrocyte Ca2+ activity before and after treatment with
a cocktail of antagonists targeting metabotropic glutamatergic and purinergic receptors.
As mentioned, both glutamate and ATP had been shown previously to trigger Ca2+
increases in astrocytes (Cornell-Bell et al., 1990; Kirischuk et al., 1995). Interestingly,
bath application of these inhibitors had no effect on spontaneous astrocyte Ca2+ events.
Based on these data, the authors concluded that the generation of spontaneous Ca2+
signals represents an intrinsic property of astrocytes that may function to modulate local
neuronal activity. It should be noted here that the authors focused primarily on events
within astrocyte somata and perisynaptic processes.

There was no mention of

spontaneous activity in perivascular endfeet.
Astrocyte Ca2+ Signaling in Disease
Given the role of spontaneous astrocyte Ca2+ signaling in modulating
neurophysiology in the healthy brain, it stands to reason that aberrant astrocyte Ca2+
signals may be causally linked to brain dysfunction after injury or disease. This concept
is heavily supported by the literature. Rodent models of epilepsy, Alzheimer’s disease
and SAH have all reported changes in astrocyte Ca2+ signaling which are thought to
contribute to the pathogenesis of their respective diseases. For example, in a study
measuring paroxysmal depolarization (PDS) of hippocampal neurons in situ, a
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phenomenon involved in triggering epileptiform discharges, Tian et al. (2005)
demonstrated strong evidence that aberrant astrocyte Ca2+ signaling preceded the
generation of PDS in nearby clusters of neurons. The authors subsequently confirmed
this finding in vivo by simultaneously measuring astrocyte Ca2+ signals and extracellular
field potentials in anesthetized animals. Going one step further, the investigators then
showed that pre-treatment of animals with antiepileptic drugs suppressed astrocyte Ca2+
oscillations and reduced seizure-like events.
The early stages of Alzheimer’s disease (AD) is accompanied by an impairment
in neuronal activity-dependent vasodilation (i.e. neurovascular coupling) (Farkas and
Luiten, 2001; Takano et al., 2007).

Consistent with a role for astrocyte endfoot Ca2+

signaling mediating local blood flow changes during neurovascular coupling, Takano et
al. (2007) found that young (2-4 months old) AD model mice exhibiting such vascular
instability also showed an increased frequency of spontaneous Ca2+ oscillations in
cortical astrocytes. Deposition of amyloid β along the walls of intra-cerebral microvessels occurs early in AD model mice (Davis et al., 2004). Takano et al. (2007) showed
that treatment of mice with amyloid β caused a time-dependent increase in astrocyte Ca2+
signaling. A more recent study expanded on these findings and demonstrated that the
hyperactive Ca2+ signaling phenotype exhibited by astrocytes in AD could be normalized
by inhibition of the Gq-coupled metabotropic purinergic receptor, P2Y1 (Delekate et al.,
2014). Based on these data, it would appear that early deposition of amyloid β causes
P2Y1-mediated enhancement of astrocyte Ca2+ signaling and disrupted neurovascular
coupling.

It is likely that these deleterious changes subsequently lead to

neurodegeneration and cognitive decline; the hallmarks of AD.
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In a rat model of aneurysmal SAH, Koide et al. (2012) found both an increase in
the amplitude of spontaneous Ca2+ events in perivascular astrocyte endfeet and inversion
of neurovascular coupling from vasodilation to vasoconstriction. Although a causal link
between these two phenomena has yet to be established, the functional consequences
observed in the SAH model (increased amplitude of spontaneous Ca2+ events and
inversion of neurovascular coupling) bear a striking resemblance to that which occurs
early in AD. Thus, it is possible that pathological changes in spontaneous astrocyte Ca2+
signaling precede the disruption of cerebral hemodynamics following SAH.
Astrocytes typically respond to CNS injury by undergoing a characteristic
hypertrophy and hyperplasia, called reactive gliosis (Sofroniew, 2009; Burda and
Sofroniew, 2014). Reactive astrocytes can be observed in each of the disease models
mentioned above (Wetherington et al., 2008; Heneka et al., 2005; Murakami et al., 2011;
Delekate et al., 2014). However, given the heterotypic responses of individual astrocytes
to environmental signals following CNS perturbation, it would be difficult to determine
whether reactive gliosis itself is accompanied by a predictable change in spontaneous
astrocyte Ca2+ signaling. Brain injury triggers a multi-cellular response and leads to the
release of numerous factors, such as ATP, TNF-α and thrombin, that could conceivably
impact astrocyte Ca2+ signaling (Shirawaka et al., 2010; Santello et al., 2011; Agulhon et
al., 2012; Pascual et al., 2012; Burda and Sofroniew, 2014).
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Purinergic Signaling
Purine and Pyrimidine Nucleotides and their Receptors
Purine and pyrimidine nucleotides (e.g. ATP, ADP, adenosine, and UTP, UDP,
respectively) contribute to a variety of cellular functions within the cytosol. However,
receptors for extracellular purine and pyrimidine nucleotides are found throughout the
body and activation of these receptors leads to the transduction of a wide range of
biological signals. Drury and Szent-Gyorgin (1929) first proposed a role for extracellular
signaling via purine nucleotides nearly a century ago when they discovered the
cardiovascular effects of intravenous administration of adenosine. Subsequent work by
Gillespie (1934) demonstrated opposing actions of ATP and adenosine on intestinal
smooth muscle contractility, indicating that these nucleotides may be signaling through
different receptors. Currently, we know there are two families of purine receptors: P1,
which are activated by adenosine, and P2, which are activated by ATP, ADP, UTP, and
UDP (Ralevic and Burnstock, 1998). For the purposes of this dissertation, we will focus
primarily on the P2 receptor family.
Purinergic P2 receptors can be subdivided into Ca2+-permeable (P2X) ion
channels, or metabotropic G protein-coupled (P2Y) receptors. There are seven P2X
receptor subtypes (P2X1-P2X7) all of which are activated by extracellular ATP. P2Y
receptors, on the other hand, have eight different subtypes (P2Y1, P2Y2, P2Y4, P2Y6,
P2Y11, P2Y12, P2Y13, and P2Y14) and are activated by a variety of extracellular ligands
(ATP, ADP, UTP, and UDP) with varying degrees of affinity (Ralevic and Burnstock,
1998). Different P2Y receptors are coupled to different G proteins. The receptors P2Y16,11

are Gq-coupled and trigger an elevation of intracellular Ca2+ when activated, whereas
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P2Y12-14 couple to Gi/o and reduce activity of adenylate cyclase. The P2 family of
receptors is broadly expressed throughout the brain and has been implicated in a variety
of neuronal and glial functions in health and disease.
Astrocyte Purinergic Signaling in Disease
Extracellular purine nucleotides are often elevated in the brain following a variety
of CNS insults, including aneurysmal SAH (Kasseckert et al., 2013). Damaged and/or
dying cells represent one source of elevated ATP following brain injury. However,
astrocytes are generally considered to be the principal source of released ATP in the CNS
(Franke et al., 2012).

Astrocytes can release ATP via Ca2+-dependent exocytosis (i.e.

vesicular release) or through hemi-channels formed by connexins and pannexins
(Montana et al., 2006; Bowser and Khakh, 2007; Kang et al., 2008). Interestingly,
astrocyte lysosomes have recently been identified as another potential source of released
ATP in the brain, although this has only been observed in cultured cells (Zhang et al.,
2007).
Astrocytes express many subtypes of P2X and P2Y receptors whose activation
causes a rise in intra-cellular Ca2+ (for reviews see: Iles and Alexandre-Ribeiro, 2004,
and Franke et al., 2012).

These P2 receptors regulate diverse functions such as

proliferation/apoptosis (Neary et al., 1996), gliotransmission (Pannicke et al., 2000; Duan
et al., 2003), and astrocyte reactivity (Brambilla et al., 1999; Abbracchio et al., 1999).
Based largely on immuno-labeling studies, the Gq-coupled P2Y1, P2Y2, and P2Y4
receptors have all been shown to be expressed on perivascular astrocyte endfeet (Simard
et al., 2003; Franke et al., 2012). Kasseckert et al. (2013) found that the ATP levels in
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cerebrospinal fluid obtained from human SAH patients were roughly 400 times higher
than that of non-SAH patients. Under healthy conditions, cerebrospinal fluid is thought
to flow into the brain parenchyma along a paravascular pathway between parenchymal
arterioles and surrounding astrocyte endfeet (Iliff et al., 2012; Iliff et al., 2013). Thus, it
is conceivable that elevated levels of ATP and/or other purine nucleotides in the
cerebrospinal fluid after SAH could trigger a pathological change in endfoot Ca2+
signaling (i.e. high-amplitude Ca2+ events). The second specific aim of this dissertation is
to determine whether purinergic signaling underlies the emergence of high-amplitude
spontaneous Ca2+ events in astrocyte endfeet following SAH.
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Figure 1-1. Two potential pathways driving neurovascular coupling.
Arachidonic acid (AA) could be released by phospholipase A2 (PLA2) following a
neuronal activity-dependent elevation of endfoot Ca2+ (left of dotted line). Enzymes
within the endfoot may metabolize AA into prostaglandin E2 (PGE2) and/or
epoxyeicosatrienoic acids (EETs) which could impact arteriolar diameter after diffusing
across the perivascular space and entering the vascular smooth muscle. However, AA
itself may also diffuse across the perivascular space and impact arteriolar diameter after
being converted to 20-hydroxyeicosatetraenoic acid (20-HETE) by smooth muscle
enzymes. Alternatively, the endfoot Ca2+ elevation could open large-conductance Ca2+activated K+ (BK) channels (right of dotted line). Increased perivascular K+ would
rapidly impact arteriolar diameter by directly influencing the smooth muscle membrane
potential.
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Figure 1-2. Schematic depicting a mechanism whereby the increased amplitude of
spontaneous endfoot Ca2+ events could lead to inversion of neurovascular coupling
after SAH.
In the absence of stimulation (left of dotted lines), perivascular astrocyte endfeet exhibit
asynchronous spontaneous Ca2+ signaling events. However, there is an increase in the
amplitude of these events after SAH. We hypothesize that the high-amplitude Ca2+
events in SAH animals cause excessive K+ efflux through endfoot BK channels leading
to an abnormal elevation of perivascular K+. Evoking a rise in endfoot Ca2+ either by
electrical field stimulation (EFS) or Ca2+ uncaging (right of dotted lines) causes a modest
BK channel-dependent elevation of extracellular K+. In healthy control animals, this
modest increase in perivascular K+ hyperpolarizes the vascular smooth muscle and causes
arteriolar dilation. In SAH animals, however, the stimulated K+ efflux could combine
with abnormally elevated K+ levels to bring perivascular K+ beyond the
dilation/constriction threshold.
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Abstract
Physiologically, neurovascular coupling (NVC) matches focal increases in neuronal
activity with local arteriolar dilation. Astrocytes participate in NVC by sensing increased
neurotransmission and releasing vasoactive agents (e.g. K+) from perivascular endfeet
surrounding parenchymal arterioles.

Recently, we demonstrated an increase in the

amplitude of spontaneous Ca2+ events in astrocyte endfeet and inversion of NVC from
vasodilation to vasoconstriction in brain slices obtained from subarachnoid hemorrhage
(SAH) model rats.

However, the role of spontaneous astrocyte Ca2+ signaling in

determining the polarity of the NVC response remains unclear.

Here, we used two-

photon imaging of Fluo-4-loaded rat brain slices to determine whether altered endfoot
Ca2+ signaling underlies SAH-induced inversion of NVC. We report a time-dependent
emergence of endfoot high-amplitude Ca2+ signals (eHACSs) after SAH that were not
observed in endfeet from un-operated animals. Further, the percentage of endfeet with
eHACS varied with time and paralleled the development of inversion of NVC. Endfeet
with eHACS were present only around arterioles exhibiting inversion of NVC.
Importantly, depletion of intracellular Ca2+ stores using cyclopiazonic acid abolished
SAH-induced eHACS and restored arteriolar dilation in SAH brain slices to two
mediators of NVC (a rise in endfoot Ca2+ and elevation of extracellular K+). These data
indicate a causal link between SAH-induced eHACS and inversion of NVC.
Ultrastructural examination using transmission electron microscopy indicated that a
similar proportion of endfeet exhibiting eHACS also exhibited asymmetrical
enlargement. Our results demonstrate that subarachnoid blood causes a delayed increase
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in the amplitude of spontaneous intracellular Ca2+ release events leading to inversion of
NVC.
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Introduction
Blood flow within the brain parenchyma is dynamically coupled to the ongoing
pattern of neuronal activity. Under physiological conditions, stimulus-evoked increases
in the frequency of neuronal action potentials elicit vasodilation of nearby parenchymal
arterioles. This phenomenon, called functional hyperemia, or neurovascular coupling
(NVC), supports brain health by spatially and temporally matching cerebral blood flow to
local tissue metabolic demand (Iadecola, 1993; Anderson and Nedergaard, 2003).
Astrocytes are key intermediaries in NVC—having projections to neuronal synapses as
well as processes (endfeet) that encase parenchymal arterioles (Araque et al., 1999). In
response to enhanced neurotransmission, astrocytes release vasoactive substances,
including potassium ions (K+), from their endfeet onto adjacent parenchymal arterioles
(Zonta et al., 2003; Filosa et al., 2006). The majority of evidence supports a role for
increased astrocyte endfoot Ca2+ in mediating neurally-evoked vasodilator release (Straub
et al., 2006; Attwell et al., 2010; Srinivasan et al., 2015;).
In addition to nerve-stimulated increases in Ca2+, spontaneous Ca2+ elevations
(200-300 nM in amplitude) lasting several seconds occur in astrocyte endfeet (Koide et
al., 2012; Shigetomi et al., 2013). In brain slices from healthy animals, these spontaneous
events resulted from IP3-dependent endoplasmic reticulum (ER) Ca2+ release (Dunn et
al., 2013). Presently, the ability of spontaneous Ca2+ signaling to influence NVC and/or
the release of vasoactive substances into the restricted perivascular space between endfeet
and parenchymal arterioles is unclear. However, we have recently demonstrated both an
increase in the amplitude of spontaneous Ca2+ events in astrocyte endfeet and inversion
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of the NVC response from vasodilation to vasoconstriction in brain slices obtained from
subarachnoid hemorrhage (SAH) model rats (Koide et al., 2012; Koide and Wellman,
2015).

Interestingly, although the NVC response switched from vasodilation to

vasoconstriction, neurally-evoked changes in endfoot Ca2+ were not altered by SAH.
Strokes caused by cerebral aneurysm rupture and SAH are associated with a high
incidence of morbidity and mortality that often manifest several days after the initial
bleed (Al-Khindi et al., 2010; Ostergaard et al., 2013). The inversion of NVC may be an
important contributor to delayed cerebral ischemia, development of neurological deficits
and poor outcome frequently observed in SAH patients (Koide et al., 2013). The goal of
the present study was to determine if altered spontaneous Ca2+ signaling in astrocyte
endfeet plays a causal role in the inversion of NVC after SAH. Here, we report that the
time-dependent emergence of high-amplitude spontaneous Ca2+ signals in astrocyte
endfeet paralleled the occurrence of inversion of NVC in brain slices from SAH model
rats. These endfoot high-amplitude Ca2+ signals (eHACSs) were only observed adjacent
to arterioles exhibiting inversion of NVC. Importantly, normal arteriolar dilation was
restored in brain slices from SAH animals when eHACSs were abolished by depletion of
ER Ca2+ stores. These results indicate that subarachnoid blood causes an increase in the
amplitude of spontaneous Ca2+ signaling events in astrocyte endfeet that leads to
inversion of NVC. Further, this work signifies that pathological changes in astrocyte
function can profoundly impact cerebral blood flow regulation.
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Materials and Methods
Rat SAH model. To mimic aneurysmal SAH, isoflurane-anesthetized Sprague-Dawley
rats (male, 10-12 week old, Charles River Laboratories) received two injections of
autologous, unheparanized arterial blood (500 µL drawn from tail artery) into the cisterna
magna as previously described (Nystoriak et al., 2011; Koide et al., 2012).

Blood

injections were given 24 h apart with the exception of animals studied at the 4 h and 24 h
time-points that received only one intracisternal injection.

Sham-operated animals

underwent identical procedures except that saline, rather than blood, was injected into the
cisterna magna. All procedures were conducted in accordance with the Guide for the
Care and Use of Laboratory Animals (eighth edition, 2011) and followed protocols
approved by the Institutional Animal Care and Use Committee at the University of
Vermont.
Simultaneous measurements of parenchymal arteriolar diameter and astrocyte endfoot
Ca2+ in freshly prepared cortical brain slices.
Brain slice preparation: Animals were euthanized by decapitation while under deep
anesthesia with pentobarbital (60 mg/kg) at the following time-points: 4 h, 24 h, and 2, 4,
7, and 14 d after SAH.

Brains were removed from animals and placed in ice-cold,

aerated (5% CO2/95% O2) artificial cerebrospinal fluid (ACSF) and coronal brain slices,
160 µm in thickness, were cut from the middle cerebral artery (MCA) territory using a
Leica VT1000S vibratome. Brain slices were then incubated with the fluorescent Ca2+
indicator dye, Fluo-4 AM (10 µM) for 1.5 hr at 29°C in ACSF containing 0.04% pluronic
acid. Using these parameters, Fluo-4 is preferentially loaded into astrocytes (Parri et al.,
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2001; Kawamura and Kawamura, 2011). In a subset of brain slices, the caged-Ca2+
compound,

1-(4,5-dimethoxy-2-nitrophenyl)-1,2-diaminoethane-N,N,N’,N’-tetraacetic

acid, tetra(acetoxymethyl ester) (DMNP-EDTA AM, 10 µM) was included with the Fluo4. Brain slices were then rinsed and maintained in aerated ACSF at room temperature
until imaged.
Simultaneous measurements of arteriolar diameter and astrocyte endfoot Ca2+: Infrareddifferential interference contrast (IR-DIC) and fluorescent images were simultaneously
recorded from brain slices using multiphoton imaging systems coupled to a Coherent
Chameleon Ti-Sapphire laser.

A BioRad Radiance multi-photon imaging system

(excitation wavelength: 820 nm, fluorescent bandpass filter: 575/150 nm, sampling
frequency ~1 Hz) with an Olympus XLUM PlanF1 20x objective (0.95 NA) was used for
the majority of studies. For these experiments, image size was 512 x 512 pixels and pixel
resolution was 0.12 µm/pixel. For studies requiring the photolysis of caged Ca2+, a Zeiss
LSM-7 multi-photon imaging system (excitation: 730 nm, fluorescent bandpass filter:
525/50 nm, sampling frequency ~2 Hz) was used with a Zeiss W Plan-APOCHROMAT
20x objective (1.0 NA). The image size for these experiments was 512 x 300 pixels, and
pixel resolution was 0.17 µm/pixel. To study NVC, electrical field stimulation (EFS; 50
Hz, 0.3 ms alternating square pulse, 3 s duration) was applied using a pair of platinum
wire electrodes (2 mm apart) to trigger neuronal action potentials (Koide et. al., 2012).
To elevate astrocyte endfoot Ca2+ independent of neuronal activation, we used photolysis
of caged-Ca2+ or “Ca2+ uncaging” in DMNP-EDTA-loaded slices.

Photolysis was

achieved using a ~0.5 s laser pulse of approximately three times the average imaging
power to uncage Ca2+ within a selected endfoot (excitation volume of ~1 µm3).
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Throughout all recordings, brain slices were continually superfused (≈ 2 mL/min) with
ACSF (aerated with 5% CO2/95% O2, pH ~7.35, 35-37°C) containing the thromboxane
A2 analog, 9,11 di-dideoxy-11α,9α-epoxymethanoprostaglandin F2α (U46619, 100 nM)
to induce a physiological level of arteriolar tone (Koide et al., 2012). Parenchymal
arteriolar segments (diameter: 3-14 µm before EFS) within the MCA territory, located at
a depth of 50-250 µm from the pial surface and surrounded by Fluo-4-loaded endfeet
were chosen for this study. Intraluminal red blood cells were observed in the majority of
recordings (89%) and their presence or absence did not correlate with a particular
vascular response to EFS or uncaging. At the end of each experiment, brain slices were
treated with ionomycin (10 µM) and 20 mM CaCl2 to obtain maximum fluorescence
intensity.
Analysis of parenchymal arteriolar diameter:

Using IR-DIC images, intraluminal

parenchymal arteriolar diameter was measured at 3 evenly spaced points along a 10 µm
segment showing the greatest response to stimulation (EFS, Ca2+ uncaging or 10 mM K+
superfusion). Diameter change, expressed as percent increase or decrease from baseline
diameter was determined from 10 s of recording prior to stimulation and then averaged
for the three points of measurement. Diameter measurements were made manually using
custom software, SparkAn, written by Dr. Adrian D. Bonev, at the University of Vermont
(Burlington, VT).
Analysis of astrocyte endfoot Ca2+: A region of interest (ROI; 1.2 x 1.2 µm) was placed
within an astrocyte endfoot that was either (1) adjacent to an arteriolar segment used to
measure diameter change after EFS or Ca2+ uncaging or (2) exhibiting spontaneous Ca2+
events in unstimulated brain slices. Baseline Ca2+ within a ROI was determined by
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averaging 10 consecutive images prior to stimulation and/or exhibiting no spontaneous
activity. The following criteria were used to define spontaneous Ca2+ events: (1) ≥30%
increase in fluorescence intensity for at least 2 consecutive images (~2 s) and (2) multiple
events observed within a ROI during a 4 min recording. The maximal fluorescence
method was used to estimate Ca2+ concentrations within a ROI (Maravall et al., 2000;
Koide et al., 2012).
Ultrastructural analysis using electron microscopy.
Transmission electron microscopy (TEM) was used to examine brain parenchymal
arterioles and surrounding astrocyte endfeet in cortical layer 2/3 of the MCA territory
(i.e. the same region examined in brain slice studies). Specimens were prepared for TEM
using standard procedures (Hayat, 1981).

Briefly, un-operated control, 2 d sham-

operated and 2 d SAH model rats were anesthetized with pentobarbital (60 mg/kg) and
fixed by transcardial perfusion at an intravascular pressure of 75 mmHg using a solution
containing 135 mM Sucrose, 0.085 mM NaH2PO4, 0.5 mM CaCl2 and 1% glutaraldehyde
(pH 7.3). Brains were then dissected from animals and fixed in 1% glutaraldehyde for an
additional 24 h.

Cortical blocks were cut, rinsed in 0.1 M cacodylate buffer and

immersed in 1% OsO4 for 4 h at 4°C and then dehydrated using a series of graded ethanol
and propylene oxide solutions, and embedded in Spurr’s resin overnight at 60° C.
Ultrathin (90 nm) sections obtained using an Ultracut microtome were contrasted with
uranyl acetate and lead citrate. A Jeol 1400 Transmission Electron Microscope was used
to obtain a series of non-overlapping images (magnification: 5000X) capturing the entire
arteriolar circumference.

Consistent with previous reports (Mathiisen et al., 2010;

McCaslin et al., 2011) the cellular structures providing sheath-like coverage of the
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abluminal surface of the arteriolar wall were identified as astrocyte endfeet. The distance
between endfeet and arteriolar smooth muscle was considered as the perivascular space.
Endfoot thickness and the perivascular space were measured at 10 random, equallyspaced points along the arteriolar circumference using ImageJ (NIH).
Statistical analysis.
Data are expressed as mean ± SEM (n: the number of observations, N: the number of
animals). Unpaired Student’s two-tailed t test was used for comparisons between two
groups.

One-way analysis of variance (ANOVA) followed by either the Tukey or

Bonferroni test were used for the post hoc comparison of multiple groups. Chi-squared
analysis was used to determine dependence between variables.
Reagents.
U46619, cyclopiazonic acid (CPA), and ionomycin were obtained from Calbiochem
(EMD Millipore, Chicago, IL).

DMNP-EDTA AM was purchased from Interchim

(Montluçon, France). Fluo-4 AM and pluronic acid were obtained from Invitrogen (Life
Technologies, Eugene, OR). All other reagents were purchased from Sigma-Aldrich (St.
Louis, MO). The composition of aCSF (in mM) was: 125 NaCl, 3 KCl, 18 NaHCO3, 1.25
NaH2PO4, 1 MgCl2, 2 CaCl2, 5 glucose and 0.4 ascorbic acid. ACSF containing 10 mM
K+ was made by iso-osmotic replacement of NaCl with KCl.
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Results
The emergence of high-amplitude spontaneous Ca2+ events in astrocyte endfeet
(eHACSs) after SAH
To explore the relationship between the inversion of NVC and the occurrence of
high-amplitude spontaneous Ca2+ signals in astrocyte endfeet, cortical brain slices from
the MCA territory were studied from SAH model rats at six time-points following
injection of blood into the subarachnoid space (4 h, 24 h, and 2, 4, 7, and 14 d). A
subarachnoid blood clot was observed adjacent to the circle of Willis on the ventral
surface of the brain between the 4 h and 4 d SAH time-points. However, at days 7 and 14
d post-SAH the clot was no longer visible. Although remote from the site of blood
injection (i.e. cisterna magna), extravascular red blood cells have been observed around
parenchymal arterioles from the MCA territory using this model of SAH (Koide et al.,
2012). Spontaneous Ca2+ events were imaged using two-photon excitation microscopy
and the fluorescent Ca2+ indicator, Fluo-4, in astrocyte endfeet surrounding parenchymal
arterioles (Fig. 1A,B). Consistent with our previous observation (Koide et al., 2012),
SAH led to a significant increase in the overall mean amplitude of spontaneous Ca2+
events following SAH (F[6,523] = 5.75; ANOVA, p < 0.0001). Post hoc comparison of the
means (Bonferroni) revealed significance at the 24 h, 2, 4, and 7 d SAH time-points (p =
0.01, p = 0.0002, p = 0.004, p = 0.03, respectively). With further analysis, we determined
that the increased mean amplitudes were due to the emergence of a sub-population of
high-amplitude Ca2+ events not observed in control animals. In brain slices from unoperated control animals, basal endfoot Ca2+ was 128 ± 4 nM and spontaneous elevations
in endfoot Ca2+ did not exceed 500 nM (range: 179 nM to 496 nM; mean: 303 ± 10 nM; n
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= 73 events from 13 endfeet). However, in brain slices from SAH animals, we often
observed high-amplitude spontaneous events (peak Ca2+, ≥500 nM; eHACSs) in addition
to spontaneous Ca2+ increases that were similar in amplitude to those observed in unoperated animals (peak Ca2+, <500 nM; “control-like events”). Thus, after SAH, endfeet
fell into one of two categories: (1) endfeet with spontaneous Ca2+ events that were all
“control-like” in amplitude, i.e., peak Ca2+ <500 nM, or (2) endfeet with a combination of
eHACSs and “control-like” spontaneous Ca2+ events. χ2 analysis indicates an association
between the incidence of endfeet exhibiting eHACSs and time (4 h, 2 d, 4 d) post-SAH
(χ2 = 8.839, df = 2, p = 0.012). For example, at the earliest time point (4 h SAH) only
~27% of endfeet had eHACSs, whereas ~83% of endfeet were eHACSs-positive in brain
slices from 2 d SAH animals (Fig. 1C). The mean amplitude (~700 nM) and frequency
of eHACSs were similar at all SAH time points (F[5, 83] = 0.81; ANOVA, p = 0.54, and
F[5,

39]

= 1.80; ANOVA, p = 0.14, respectively). When compared with events from

control animals, post hoc comparison of the means (Bonferroni) demonstrated that there
was no change in the amplitude of “control-like” spontaneous Ca2+ events at any timepoints after SAH, irrespective of the presence or absence of eHACSs (p > 0.05 in each
group, Table 1).

These data demonstrate that SAH leads to the time-dependent

emergence of high-amplitude spontaneous Ca2+ events (i.e. eHACSs) not observed in
control animals.
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The inversion of NVC parallels the emergence of eHACSs after SAH
We next examined whether the inversion of NVC followed a similar timedependent pattern of development as that of eHACSs after SAH. In brain slices from
control animals, EFS-evoked neuronal activation caused the anticipated NVC response: a
rise in astrocyte endfoot Ca2+ followed by vasodilation of the adjacent arteriole (Fig. 2A;
n = 6 arterioles, N = 6 animals). Similar vasodilatory NVC responses were observed in
all brain slices obtained from 4 h SAH animals (n = 6 arterioles, N = 5 animals).
However, EFS-induced vasoconstriction (i.e. inversion of NVC) was observed in brain
slices from animals at later SAH time-points. Inversion of NVC peaked at 2 d SAH with
100% of brain slices (n = 7 arterioles, N = 6 animals) exhibiting EFS-induced
vasoconstriction, then steadily declined at later time-points (Fig. 2B,C).

One-way

ANOVA demonstrated a main effect of time post-SAH on EFS-evoked changes in
arteriolar diameter (F[6, 40] = 4.961, p = 0.0007). Post hoc multiple comparisons of the
means (Bonferroni) revealed significance at the 2 and 4 d SAH time-points (p = 0.001,
0.01, respectively). Although SAH influenced the polarity of EFS-induced vascular
responses, evoked increases in endfoot Ca2+ in brain slices from SAH animals were
similar to those in the control group (Table 2, F[6,39] = 0.52; ANOVA, p = 0.79). There
also was no difference in the mean arteriolar diameter before EFS between groups (F[6,40]
= 1.74; ANOVA, p = 0.14). In two instances, one at the 24 h and one at the 7 d SAH
time-points, we observed opposing vascular responses in brain slices from the same
animal, suggesting that inversion of NVC develops and resolves non-uniformly
throughout brain cortex. Consistent with our hypothesis that the emergence of eHACSs
dictates the polarity of the neurovascular response after SAH, the time course of
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inversion of NVC was remarkably similar to the time course of the emergence of
astrocyte endfeet exhibiting eHACSs (Fig. 2D).
To further explore causality between the emergence of eHACSs and inversion of
NVC, we captured both phenomena in single continuous recordings (3 min recording of
spontaneous activity followed by EFS) of brain slices obtained from 24 h SAH animals.
Here, we chose to study the 24 h SAH time-point because approximately half of the brain
slices from these animals exhibited normal NVC (EFS-induced vasodilation) while the
remaining slices exhibited inversion of NVC (EFS-induced vasoconstriction).

As

anticipated, endfeet in brain slices from 24 h SAH animals displayed either only “controllike” spontaneous Ca2+ events (i.e. no eHACSs) or exhibited a combination of “controllike” events and eHACSs during the initial 3 min of recordings capturing spontaneous
Ca2+ events (Fig. 3A). EFS-induced vasodilation (12 ± 4% increase in diameter, n = 4
arterioles, N = 4 animals) occurred in all brain slices exhibiting only “control-like”
spontaneous Ca2+ events (mean amplitude of spontaneous Ca2+ events: 284 ± 16 nM,
range: 189-485 nM, 32 events in four brain slices from four animals, Fig. 3B).
Conversely, inversion of NVC (EFS-induced vasoconstriction, 17 ± 7% decrease in
diameter, n = 5 arterioles, N = 5 animals) was observed in all brain slices containing
eHACSs-positive endfeet (71 events in 5 brain slices from 5 animals, Fig. 3B). The
presence or absence of eHACSs did not impact EFS-evoked increases in astrocyte
endfoot Ca2+ or the overall frequency of spontaneous Ca2+ events (Fig. 3C,D; p = 0.46;
two-tailed t test, p = 0.33; two-tailed t test, respectively). In two cases, brain slices with
endfeet exhibiting eHACSs also had endfeet where eHACSs were not observed along the
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same arteriolar segment. These results are consistent with the emergence of eHACSs
causing inversion of NVC after SAH.

Abolition of eHACSs restores vasodilatory responses in brain slices from SAH
animals
Release of Ca2+ from the ER underlies the generation of spontaneous Ca2+ events
in astrocyte endfeet of healthy animals (Dunn et al., 2013). To examine the role of ER
Ca2+ release in the generation of eHACSs, cyclopiazonic acid (CPA), a selective
sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) inhibitor, was used to deplete
astrocyte ER Ca2+ stores. In brain slices from control animals, CPA treatment (30 µM,
25 min) abolished spontaneous endfoot Ca2+ events (Fig. 4A), as expected. Importantly,
CPA also abolished all spontaneous Ca2+ signals, including eHACSs, in brain slices from
2 d SAH animals indicating that SAH-induced eHACSs are mediated via ER Ca2+ release
(Fig. 4B).
Using CPA to deplete ER Ca2+, we next examined whether the elimination of
SAH-induced eHACS could restore vasodilatory responses typical of NVC. However,
because EFS-evoked vasodilation is also dependent on astrocyte endfoot ER Ca2+ release
(Straub et al., 2006), we targeted two elements downstream of neuronal activation in the
NVC signaling cascade (increased endfoot Ca2+ and elevated perivascular K+). First,
two-photon photolysis of caged Ca2+ was used to induce a focal (excitation volume ~1
µm3) rise in endfoot Ca2+. Consistent with EFS-induced vascular responses (Fig. 2),
uncaging Ca2+ in astrocyte endfeet in the absence of CPA caused a similar amplitude
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endfoot Ca2+ transient in all brain slices (Control: 436 ± 35 nM; SAH: 417 ± 32 nM p =
0.47; two-tailed t test), but caused vasodilation in brain slices from control animals and
vasoconstriction in brain slices from 2 d SAH animals. Treatment of brain slices from
control animals with CPA did not affect vasodilation induced by photolysis of caged Ca2+
in astrocyte endfeet (Fig. 4C, p = 0.243; two-tailed t test). However, in brain slices from
2 d SAH animals, CPA treatment (i.e., abolishing eHACSs) reversed Ca2+ uncaging
responses from constriction to dilation (Fig. 4D, p < 0.0001; two-tailed t test). In the
presence of CPA, the amplitude of endfoot Ca2+ transients induced by uncaging Ca2+
were again similar between groups (Control: 365 ± 53 nM; SAH: 310 ± 50 nM, p = 0.83;
two-tailed t test). These results indicate that abolishing eHACSs restored normal
astrocyte-vascular signaling in brain slices from SAH animals (Fig. 4E).
Modest increases in the extracellular/perivascular K+ concentration play an
important role in astrocyte-to-smooth muscle communication during NVC (Filosa et al.,
2006; Girouard et al., 2010).

Typically, neurally-evoked increases in endfoot Ca2+

activate large-conductance Ca2+-activated K+ (BK) channels on astrocyte endfeet, causing
an estimated 5-10 mM increase in perivascular K+ and vasodilation via activation of
smooth muscle strong inwardly rectifying K+ (KIR) channels (Filosa et al., 2006; Girouard
et al., 2010). Previous studies have mimicked neurally-evoked endfoot K+ efflux by
increasing the K+ concentration in the brain slice superfusate from 3 mM to 10 mM
(Filosa et al., 2006; Girouard et al., 2010; Koide et al., 2012). Here, we examined the
effect of K+-induced changes in arteriolar diameter in brain slices obtained from control
and 2 d SAH animals in the presence and absence of endfoot spontaneous Ca2+ events.
Similar to the inversion of NVC, increasing extracellular K+ from 3 to 10 mM in brain
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slices with intact astrocyte ER Ca2+ (i.e., endfeet exhibiting spontaneous Ca2+ events)
caused arteriolar dilation in brain slices from un-operated animals and vasoconstriction in
brain slices from 2 d SAH animals. As with Ca2+ uncaging, abolishing spontaneous Ca2+
events with CPA (30 µM, 25 min) restored arteriolar dilation in response to 10 mM
extracellular K+ in brain slices from 2 d SAH animals and had no effect on K+-induced
vasodilation in brain slices from control animals (Fig. 4F, p < 0.0001; two-tailed t test, p
= 0.56; two-tailed t test, respectively). Thus, abolishing eHACSs restored vasodilatory
responses in brain slices after SAH.

Asymmetrical enlargement of perivascular astrocyte endfeet after SAH
Central nervous system (CNS) pathologies such as traumatic brain injury,
ischemic stroke and SAH are associated with astrocyte hypertrophy and reactive gliosis
(Murakami et al., 2011; Burda and Sofroniew, 2014). To explore the impact of SAH on
the ultrastructure of the gliovascular interface (i.e., astrocyte endfeet and parenchymal
arterioles), we used TEM to image brain cortex from control, 2 d sham-operated and 2 d
SAH model animals. Astrocyte endfeet surrounding parenchymal arterioles from control
and sham-operated animals exhibited a thin, uniform, sheath-like morphology (Fig. 5A).
In contrast, perivascular endfeet of SAH animals exhibited regions of asymmetrical
thickening that contained numerous subcellular organelles, including lysosomes (Fig.
5A). Lysosomes were observed in 12 of 16 endfeet after SAH, but were not observed in
endfeet from control or sham-operated animals. Remarkably, in 2 d SAH animals, the
percentage of endfeet exhibiting asymmetrical hypertrophy (~81%, 13/16 endfeet) was
similar to the percentage of endfeet exhibiting eHACS (~83 %; Fig. 1D). Using a
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threshold of 3-times the mean thickness of control endfeet (~690 nm), we determined that
~17% of the arteriolar circumference is surrounded by an enlarged endfoot after SAH
(Fig. 5C, Tukey, p < 0.0001 vs control, p = 0.0008 vs sham). Interestingly, despite
enlargement of endfoot processes, the distances measured between the endfeet and
arteriolar smooth muscle (i.e., the perivascular space) in these samples were similar
between groups (~70 nm, Fig. 5B, F[2,627] = 1.17; ANOVA, p = 0.31). These results
suggest a possible link between structural changes in perivascular endfeet after SAH and
altered endfoot Ca2+ signaling (i.e. eHACSs).

Discussion
This study provides evidence that the emergence of high-amplitude spontaneous
Ca2+ events within astrocyte endfeet underlies SAH-induced inversion of NVC. Highamplitude Ca2+ signals or “eHACSs” were absent in brain slices from un-operated control
animals, and were present only in endfeet surrounding arterioles exhibiting inversion of
NVC. Further, abolishing eHACSs through pharmacologic depletion of ER Ca2+ restored
typical vasodilatory responses to two elements involved in the NVC signaling cascade —
increased endfoot Ca2+ and modest elevation of extracellular K+. BK channels, localized
to the endfoot membrane (Price et al., 2002), are the most likely Ca2+ sensor responsible
for transducing eHACSs into a pathological vascular response. Astrocyte BK channels
are an important component of neurovascular communication (Filosa et al., 2006;
Girouard et al., 2010; Koide et al., 2012) and contain auxiliary β4 subunits (Seidel et al.,
2011) conferring a high level of Ca2+-sensitivity to these channels (Horrigan and Aldrich,
2002; Bai et al., 2011). Thus, considering the Ca2+-sensitivity and large single channel
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conductance of BK channels, it is likely that SAH-induced eHACSs cause a substantial
increase in BK-mediated K+ efflux. As the restricted perivascular space between endfeet
and arteriolar myocytes is estimated to be less than 100 nm (Nagelhus et al., 1999) (see
also, Fig. 5B), relatively small changes in the number of K+ ions would significantly
impact the K+ concentration within the micro-domain surrounding parenchymal arterioles
(Girouard et al., 2010). Cerebral arteries are highly sensitive to changes in extracellular
K+ (Knot et al., 1996; Zaritsky et al., 2000). Modest increases in extracellular K+ (≤20
mM) cause arteriolar dilation via activation of smooth muscle KIR channels (Knot et al.,
1996; Filosa et al., 2006; Girouard et al., 2010). However, larger increases (>20 mM)
cause a depolarizing shift in the K+ equilibrium potential of smooth muscle that leads to
enhanced Ca2+ entry through L-type voltage-dependent Ca2+ channels and arteriolar
constriction (Knot and Nelson, 1998). Our previous work indicates that SAH-induced
inversion of NVC is a result of abnormally elevated basal perivascular K+ that, when
combined with neurally-evoked K+ efflux, leads to smooth muscle membrane potential
depolarization and a switch in the polarity of the vascular response from dilation to
constriction (Koide et al., 2012). We now demonstrate that altered spontaneous Ca2+
signaling in the form of eHACSs dictates the polarity of NVC after SAH. These results
are consistent with the concept that SAH-induced eHACSs enhance BK channel activity
in the endfeet causing an increase in basal perivascular K+ and inversion of NVC.
This work expands upon a growing body of research indicating that SAH-induced
cortical infarcts and poor clinical outcome are due to disruption of blood flow within the
brain micro-circulation (Dreier et al., 2002; Ishiguro et al., 2002; Rabinstein et al., 2005;
Pluta et al., 2009; Nystoriak et al., 2011; Ostergaard et al., 2013). Microvasculature
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dysfunction after SAH would be predicted to cause cerebral infarction in relatively small,
spatially-defined regions due to the paucity of collaterals within the brain parenchyma
(Nishimura et al., 2007). Roughly 60% of patients exhibit diffuse ischemic brain lesions
following SAH (Hijdra et al., 1986). Further, it has been suggested that the mechanism
underlying diffuse brain injury differs from that which causes cell death near the site of
aneurysm rupture (Rabinstein et al., 2005). While neuronal viability was not directly
examined in the current study, the inversion of NVC likely precedes substantial cell death
or neuronal injury after SAH as EFS-evoked changes in endfoot Ca2+ were comparable in
brain slices from control and SAH animals. Previous studies have also shown altered ion
channel function and/or expression in vascular smooth muscle cells following exposure
to the blood component, oxyhemoglobin (Ishiguro et al., 2005; Wellman, 2006; Link et
al., 2008). Thus, it is possible that ischemic events following SAH result from the
combined effects of inversion of NVC and other actions of SAH, including a direct
increase in arteriolar smooth muscle contractility (Nystoriak et al., 2011). Future studies
will be required to establish the contribution of pathological astrocyte Ca2+ signaling and
inversion of NVC in the development of delayed cerebral ischemia following SAH.
Astrocytes typically respond to CNS perturbations (including SAH) by
undergoing a characteristic hypertrophy known as reactive gliosis (Murakami et al.,
2011; Burda and Sofroniew, 2014). Although the morphological and molecular changes
associated with reactive gliosis are well-described (Sofroniew, 2009), the functional
consequences remain unclear. Recent in vivo measurements of astrocyte Ca2+ signaling
using a mouse model of familial Alzheimer’s disease demonstrated a “hyperactive” Ca2+
signaling phenotype in reactive astrocytes (Delekate et al., 2014).
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Importantly, the

aberrant Ca2+ signals present in endfeet were associated with spontaneous
vasoconstrictions of the neighboring arterioles. These data provide an interesting parallel
between the phenomena we observe after SAH (i.e. emergence of endfeet exhibiting
eHACSs, inversion of NVC, and asymmetrical endfoot hypertrophy) and the functional
alterations observed in a mouse model of Alzheimer’s disease.
The results from our TEM studies demonstrated asymmetrical enlargement of
astrocyte endfeet following SAH.

While endfoot swelling has been suggested to

compress cerebral micro-vessels after SAH (Ostergaard et al., 2013), it is unlikely that
the endfoot enlargement we are reporting directly causes arteriolar narrowing, as we
detected no change in arteriolar diameter prior to EFS at any time-points after SAH
(Table 2). Further, we found no change in the width of the perivascular space using TEM
(Fig. 5). However, these static TEM measurements of the perivascular space were made
using perfusion-fixed tissue susceptible to spacing artifacts.

It is also important to

consider that the perivascular space surrounding parenchymal arterioles provides a
critical and dynamic conduit for the exchange of CSF with brain interstitial fluid (ISF)
(Iliff et al., 2012; Iliff et al., 2013). Considering previous work showing that increased
arousal decreases ISF-CSF fluid exchange (Xie et al., 2013), it is possible that increases
in arteriolar diameter during vasodilatory NVC coincide with decreases in perivascular
volume. Conversely, vasoconstrictive NVC would be predicted to increase perivascular
volume and enhance ISF-CSF exchange. Thus, it is conceivable that the inversion of
NVC after SAH represents an adaptive response promoting the clearance of bloody CSF.
Our data indicate that SAH-induced high-amplitude Ca2+ signaling events, in the
form of eHACSs, result from increased Ca2+ release from subcellular ER stores (Fig. 4).
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However, the cellular basis underlying the enhanced release of Ca2+ after SAH remains to
be determined. An increase in ER Ca2+ load, or increased expression/sensitivity of IP3
receptors could potentially contribute to the emergence of eHACSs after SAH. However,
increased production of IP3 could also underlie SAH-induced eHACSs. It is generally
appreciated that endfoot Ca2+ signals result from activation of Gq-coupled receptors and
the production of IP3 (Fiacco and McCarthy, 2006; Straub et al., 2006). Astrocytes
express a multitude of Gq-coupled receptors that could play a role in the generation of
eHACSs. Previously, purinergic signaling was been implicated in the hyperactive Ca2+
signaling phenotype observed in reactive astrocytes in an Alzheimer’s disease model
(Delekate et al., 2014). Further, the Gq-coupled purinergic receptors, P2Y2 and P2Y4, are
expressed in astrocyte endfeet (Simard et al., 2003), and up-regulation of purinergic
signaling has been implicated after SAH (Kasseckert et al., 2013).

Interestingly,

astrocyte lysosomes are capable of ATP release (Zhang et al., 2007) and we observed
organelles appearing to be lysosomes in endfeet of SAH, but not control animals (Fig.
5A). There is strong evidence from Alzheimer’s disease models that astrocyte lysosomes
are involved in the clearance of β-amyloid plaques (Funato et al., 1998; Wyss-Coray et
al., 2003). Considering the distribution of red blood cells and blood products along the
parenchymal arteriolar walls after SAH (Koide et al., 2012), the presence of enlarged
endfeet containing lysosomes in our TEM samples may indicate a role for astrocytes in
the clearance of extravascular blood components. However, future studies are necessary
to determine the role of reactive astrogliosis and purinergic signaling in the development
of SAH-induced eHACSs and inversion of NVC.
64

In summary, our results indicate a causal link between the emergence of highamplitude spontaneous Ca2+ events in astrocyte endfeet (i.e. eHACSs) and SAH-induced
inversion of NVC. These findings identify astrocytes as a key player in SAH-induced
disruption of cortical blood flow. Further work targeting the impact of SAH on astrocyte
function may lead to the development of new therapeutic strategies to treat brain
pathologies such as hemorrhagic stroke.
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Figure 2-1. Emergence of endfoot high-amplitude Ca2+ signals (eHACS) following
SAH
A, (Top) Images of parenchymal arterioles and surrounding astrocyte endfeet in brain
slices obtained from control (left) and 2 d SAH model rats (right). The red dashed lines
on grey-scale IR-DIC images depict intraluminal diameter. Overlapping pseudocolormapped fluorescent Ca2+ images of endfeet were simultaneously acquired using twophoton microscopy. Scale bars are 10 µm. (Bottom) Time-lapse images from the area
within the yellow dotted box in top panels. B, Spontaneous Ca2+ activity recorded from
1.2 x 1.2 µm regions of interest shown in the black squares in panel A. Black arrowheads
indicate the spontaneous Ca2+ events depicted in the time-lapse series of A. Red circles
indicate eHACSs (peak Ca2+ levels ≥500 nM). C, Number of endfeet with and without
eHACSs (red and gray dots, respectively) observed in control (N = 8 animals) and SAH
model animals (N = 6-8 animals per time point). χ2 analysis indicates an association
between the incidence of endfeet exhibiting eHACSs and time (4 h, 2 and 4 d) post-SAH
(χ2 = 8.839, df = 2, p = 0.012).
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Figure 2-2. The inversion of NVC parallels the emergence of eHACSs in brain slices
from SAH model animals.
A,B, EFS-induced changes in arteriolar diameter and astrocyte endfoot Ca2+ in brain
slices from control (A) and 2 d SAH animals (B). (Top) IR-DIC images with
simultaneously acquired pseudo-colored Ca2+ fluorescence maps showing arteriolar
diameter (depicted in red dashed line) and astrocyte endfoot Ca2+ before and after EFS.
Scale bars are 10 µm. (Bottom) EFS-evoked changes in endfoot Ca2+ and arteriolar
diameter corresponding to the above images. Although EFS caused a similar increase in
astrocyte endfoot Ca2+ (black traces), it was associated vasodilation (green trace) in brain
slices from control animals and vasoconstriction (red trace) in brain slices from 2 d SAH
animals. C, Summary of EFS-induced arteriolar responses in brain slices from control
and SAH model animals. Black lines represent the mean change in diameter per study
group (n = 6-8 arterioles from 4-6 animals per group). *p < 0.05; ** p < 0.01 (one-way
ANOVA, followed by Bonferroni’s post hoc test). D, Relationship between the
percentage of endfeet with eHACSs and percentage of arterioles exhibiting inversion of
NVC at various time-points after induction of SAH. Arrows demonstrate the progression
of time.
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Figure 2-3. The presence of eHACSs is associated with inversion of NVC.
A, Continuous in tandem recordings of spontaneous Ca2+ events and EFS-evoked changes
in arteriolar diameter and astrocyte endfoot Ca2+ from brain slices of 24 h SAH animals.
In brain slices with endfeet lacking eHACSs (left), EFS triggered a rise in endfoot Ca2+
and vasodilation of the adjacent arteriole. However, when eHACSs were present in the
surrounding endfeet (right), a similar EFS-evoked rise in endfoot Ca2+ elicited
vasoconstriction (i.e., inversion of NVC).

B, Summary of EFS-induced changes in

arteriolar diameter in brains slices with and without endfeet exhibiting eHACSs (n = 4 or
5 arterioles, N = 4 or 5 animals). ** p < 0.01 (two-tailed t test). C, Summary of the EFSinduced rise in endfoot Ca2+ in brain slices with or without eHACSs (n = 7-11 endfeet, N
= 4-5 animals). D, Summary of the frequency of spontaneous Ca2+ events in brain slices
with or without eHACSs (n = 7-11 endfeet, N = 4 or 5 animals).
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Figure 2-4. Abolishing eHACSs restores arteriolar dilation in brain slices from
SAH animals
A,B,

Depletion of intracellular Ca2+ stores with cyclopiazonic acid (CPA, 30 µM)

treatment abolished spontaneous Ca2+ events in astrocyte endfeet from control and 2 d
SAH animals (n = 5-6 endfeet per group, N = 4 animals per group). C,D, Changes in
endfoot Ca2+ and arteriolar diameter evoked by photolysis (uncaging) of caged-Ca2+ in
brain slices from control (C) and 2 d SAH animals (D), with (top) or without spontaneous
Ca2+ signals (bottom), i.e., ± CPA treatment. E, Summary data depicting percent change
in arteriolar diameter induced by Ca2+ uncaging in the presence or absence of CPA (n = 4
arterioles per group, N = 3-4 animals per group). F, Summary data depicting percent
change in diameter evoked by increasing extracellular K+ in ACSF superfusate from 3
mM to 10 mM in the presence or absence of CPA (n = 6-10 arterioles per group, N = 4-5
animals per group). ** p < 0.01 (two-tailed t test).
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Figure 2-5. Astrocyte endfeet with asymmetrical hypertrophy encase parenchymal
arterioles following SAH
A, (Top) Low-magnification TEM images of parenchymal arterioles in cerebral cortices
obtained from 2 d sham-operated and 2 d SAH model animals. Astrocyte endfeet are
highlighted in yellow.

(Bottom) High-magnification images of the arteriolar wall

(endothelial and smooth muscle cell layers) as well as the surrounding astrocyte endfoot
from within the black boxes. Lysosomes (round electron dense structures) were only
observed in areas of enlarged endfeet from SAH animals. B, Distance between astrocyte
endfeet and arteriolar smooth muscle (i.e., width of the perivascular space) measured at
10 random equally spaced locations along the arteriolar circumference. (n = 16-27
arterioles per group, N = 4-5 animals per group). C, Summary of endfoot hypertrophy.
Data are presented as the percentage of the arteriolar circumference surrounded by an
enlarged endfoot (i.e., >3 times the mean thickness of control endfeet) (n = 16-27
arterioles per group, N = 4-5 animals per group). ** p < 0.01 vs control, ## p < 0.01 vs
sham (one-way ANOVA, followed by the Tukey test).
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Table 2-1. Impact of SAH on spontaneous Ca2+ events in astrocyte endfeet

Endfeet without
eHACSs
Basal endfoot Ca2+
(nM)
Range of Ca2+ event
amplitudes (nM)
Mean amplitude
(nM)
Frequency of
spontaneous Ca2+
events (Hz)
n, N (endfeet,
animals)
Endfeet with
eHACSs
Basal endfoot Ca2+
(nM)

Control

4h
SAH

24 h
SAH

2d
SAH

4d
SAH

7d
SAH

14 d
SAH

128 ± 4

121 ± 3

125 ± 7
ns

134 ±
19

128 ± 7

121 ± 6

125 ± 4

ns

ns

ns

ns

ns

179 –
496

166 –
484

161 –
477

214 –
496

208 –
458

192 –
491

187 –
470

302 ± 10

270 ±
11

300 ±
17

348 ±
31

310 ±
14

313 ±
18

293 ±
11

0.021 ±
0.004 ns

0.022 ±
0.005 ns

0.020 ±
0.011 ns

0.017 ±
0.002 ns

0.024 ±
0.003 ns

0.019 ±
0.004 ns

11, 4

6, 5

2, 7

7, 6

7, 5

11, 5

129 ± 4

131 ± 6

131 ± 4

ns

0.024 ±
0.003
13, 8

-

124 ± 7

ns

ns

128 ± 3 127 ± 4
NS

NS

ns

NS

ns

NS

ns

NS

Range of Ca2+ event
amplitudes (nM)

-

181 –
866

229 –
1618

182 –
1323

197 –
1141

195 –
1244

218 –
871

Mean amplitude of
control-like events
(nM)

-

294 ±
18

321 ±
16

312 ±
11

292 ±
14

289 ±
15

356 ±
24

Mean amplitude of
eHACSs (nM)

-

605 ±
43

738 ±
72

691 ±
40

769 ±
55

770 ±
73

758 ±
32

Frequency of
spontaneous Ca2+
events (Hz)

-

0.025 ±
0.005

0.024 ±
0.005

0.034 ±
0.004

0.019 ±
0.004

0.017 ±
0.002

0.019 ±
0.004

eHACSs (percent of
total events)

-

39.5 ±
12.6

41.0 ±
3.4

37.6 ±
8.5

46.6 ±
9.7

39.6 ±
8.6

32.7 ±
12.1

0, 8

4, 4

7, 5

10, 7

10, 6

9, 5

4, 5

n, N (endfeet,
animals)

NS

NS

NS

NS

81

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

All Endfeet
Total spontaneous
Ca2+ events

73

81

72

94

78

63

70

One-way analysis of variance (ANOVA) followed by Bonferroni test were used for the post hoc
comparison of multiple groups. ns: not statistically different (p > 0.05) compared to control
group in endfeet without eHACSs. NS: not statistically different (p >0.05) compared to 4 h SAH
group in endfeet with eHACSs.
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Table 2-2. Impact of SAH on NVC
Control

4h
SAH

24 h
SAH

2d
SAH

4d
SAH

7d
SAH

14 d
SAH

Brain slices with intact NVC (i.e. arteriolar dilation)
Arteriolar diameter
before EFS (µm)
Endfoot Ca2+
before EFS (nM)
Endfoot Ca2+
after EFS (nM)
n, N (slices,
animals)

8.7 ±
1.3
139 ±
19
421 ±
39

6.5 ±
0.8

5.0 ± 0.6

-

6.8

8.3 ±
0.8

6.1 ± 0.7

127 ± 8

137 ± 8

-

137

128 ± 6

123 ± 8

427 ±
30

404 ± 32

-

388

378 ±
38

413 ± 27

6, 6

6, 5

3, 4

0, 5

1, 5

4, 6

5, 4

Brain slices with inversion of NVC (i.e. arteriolar constriction)
Arteriolar diameter
before EFS (µm)
Endfoot Ca2+
before EFS (nM)
Endfoot Ca2+
after EFS (nM)
n, N (slices,
animals)

-

-

5.7 ± 0.8

7.2 ±
1.5

9.2 ±
1.6

5.1 ±
1.0

4.2

-

-

128 ± 6

128 ± 4

135 ± 3

122 ± 5

122

-

-

361 ± 16

377 ±
24

394 ±
37

440 ±
15

361

0, 6

0, 5

5, 4

7, 5

6, 5

3, 6

1, 4
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Chapter 3: Purinergic signaling triggers endfoot high-amplitude Ca2+
signals and causes inversion of neurovascular coupling after
subarachnoid hemorrhage
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Departments of Pharmacology1 and Surgery2, Division of Neurosurgery, University of
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Abstract
Neurovascular coupling (NVC) is the process whereby astrocytes match focal increases
in neuronal activity with local arteriolar dilation by releasing vasoactive substances (e.g.
K+ ions) from perivascular endfeet. Previously, we demonstrated that an emergence of
endfoot high-amplitude Ca2+ signals (eHACSs) after subarachnoid hemorrhage (SAH)
caused a pathological shift in NVC from vasodilation to vasoconstriction. Extracellular
purine nucleotides (e.g. ATP) can trigger astrocyte Ca2+ oscillations, and may be elevated
following SAH.

Here, we imaged Fluo-4-loaded rat brain slices using two-photon

fluorescence microscopy to determine the role of purinergic signaling in the generation of
SAH-induced eHACSs and inversion of NVC. We report that broad-spectrum inhibition
of purinergic (P2) receptors using suramin selectively blocked eHACSs and restored
vasodilatory NVC in brain slices from SAH animals.

Importantly, eHACSs were

selectively abolished using a cocktail of inhibitors targeting Gq-coupled P2Y receptors.
Further, activation of P2Y receptors in brain slices from un-operated animals triggered
high-amplitude Ca2+ events resembling eHACSs and disrupted NVC.

Neither

tetrodotoxin nor bafilomycin A1 had an effect on eHACSs suggesting that purine
nucleotides are not released by ongoing neurotransmission after SAH. Together, these
results indicate that purinergic signaling via P2Y receptors contributes to SAH-induced
eHACSs and inversion of NVC.
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Introduction
Aneurysmal subarachnoid hemorrhage (SAH) is associated with substantial
morbidity and mortality against which current therapeutic options have limited efficacy 1.
The development of multifocal cortical infarcts days to weeks after the initial bleed is a
frequent complication jeopardizing the survival and long-term outcome of SAH patients
2-4

. Perfusion deficits within brain cortex are generally appreciated to contribute to the

widespread ischemia following SAH 5, 6. However, the signaling pathways linking SAH
to micro-vascular dysfunction are not fully understood.
Intra-cerebral (parenchymal) arterioles represent a significant bottleneck to
cortical perfusion, and are regulated extrinsically by surrounding astrocyte endfeet 7, 8. In
the healthy brain, increased neuronal activity triggers a rise in astrocyte endfoot Ca2+
causing the release of vasoactive substances (e.g. K+ ions) into the restricted perivascular
space and parenchymal arteriolar dilation 9. This functional hyperemic response, also
referred to as neurovascular coupling (NVC), ensures adequate delivery of O2 and other
nutrients to areas of the brain with increased metabolic demand.

Previously, we

demonstrated that an emergence of spontaneous endfoot high-amplitude Ca2+ signals
(eHACSs) caused inversion of NVC from vasodilation to vasoconstriction in brain slices
obtained from SAH model animals

10, 11

.

A shift in NVC from vasodilation to

vasoconstriction may contribute to the development of focal ischemia after SAH by
restricting blood flow to active brain regions. However, the cellular basis underlying the
generation of eHACSs after SAH has not been determined.
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The goal of this study was to determine whether enhanced purinergic signaling
underlies the generation of eHACSs and inversion of NVC after SAH.

Astrocytes

broadly express both ionotropic and metabotropic purinergic receptors that trigger a rise
in intracellular Ca2+ when activated

12, 13

. Increased signaling via extracellular purine

nucleotides (e.g. ATP) is common after brain injury; including aneurysmal SAH 12, 14 and
studies have reported elevated levels of ATP in the cerebral spinal fluid (CSF) after SAH
14, 15

.

Interestingly, purinergic signaling has also been reported to cause aberrant

astrocyte Ca2+ elevations that are associated with vascular instability and disrupted NVC
in a mouse model of Alzheimer’s disease 16, 17.
Here, using combined infrared-differential interference contrast (IR-DIC) and
two-photon fluorescence microscopy, we report that inhibition of Gq-coupled P2Y
purinergic receptors abolished eHACSs and restored vasodilatory NVC in brain slices
obtained from SAH model animals. However, block of P2Y receptors did not affect
astrocyte Ca2+ signaling in brain slices from control animals and inhibition of ionotropic
P2X receptors did not alter Ca2+ signaling in either the control or SAH groups. Further,
we show that activation of P2Y receptors in brain slices from control animals mimicked
SAH by triggering high-amplitude endfoot Ca2+ events resembling eHACSs and
disrupting NVC responses. This work identifies astrocyte P2Y receptors as an important
component of SAH pathology and a novel potential therapeutic target in the treatment of
micro-vascular dysfunction following cerebral aneurysm rupture.
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Materials and Methods
Rat SAH model.

The double-injection cisterna magna model was used to mimic

aneurysmal SAH, as previously described

10, 18

.

Briefly, autologous, unheparanized

arterial blood (0.5 mL drawn from the tail artery) was injected into the cisterna magna of
isoflurane-anesthetized Sprague-Dawley rats (male, 10-12 weeks old, Charles River
Laboratories). This surgical procedure was repeated following a 24 h recovery period.
SAH model animals were euthanized at 2 d (48 h) following the first injection of
subarachnoid blood. The 2 d SAH time point was chosen because we previously found
that at this time point the vast majority of astrocyte endfeet (~80%) exhibit eHACSs;
defined as spontaneous (i.e., non-stimulated) events with endfoot Ca2+ exceeding 500 nM
11

. The 2 d SAH time-point also coincided with the highest percentage (100%) of brain

slices exhibiting inversion of NVC. Un-operated animals served as the control group. All
procedures were conducted in accordance with the Guide for the Care and Use of
Laboratory Animals (eighth edition, 2011) and followed protocols approved by the
Institutional Animal Care and Use Committee at the University of Vermont.
Simultaneous measurement of arteriolar diameter and astrocyte endfoot Ca2+ in cortical
brain slices.
Brain slice preparation: Animals were euthanized by decapitation while under deep
anesthesia with pentobarbital (60 mg/kg). Coronal brain slices (160 µm thick) were cut
in ice-cold, aerated (5 % CO2/95 % O2) artificial cerebral spinal fluid (ACSF) using a
Leica VT1000S vibratome.

Brain slices were incubated with the fluorescent Ca2+

indicator, Fluo-4 AM (10 µM) for 1.5 h at 29 °C in aerated ACSF containing 0.04 %
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pluronic acid. Under these conditions, Fluo-4 preferentially loads into astrocytes

19

.

After incubating with Fluo-4 AM, brain slices were rinsed and maintained in aerated
ACSF at room temperature prior to imaging.
Simultaneous recordings of arteriolar diameter and endfoot Ca2+: A BioRad Radiance
multi-photon imaging system (excitation wavelength: 820 nm, fluorescent bandpass
filter: 575/150 nm, sampling frequency ~1 Hz) coupled to a Coherent Chameleon TiSapphire laser was used to simultaneously obtain infrared-differential interference
contrast (IR-DIC) and fluorescent brain slices images. Arteriolar segments (cortical layer
2/3, middle cerebral artery territory) that were surrounded by fluo-4-loaded endfeet were
chosen for study. Spontaneous endfoot Ca2+ signals were recorded in the absence of
stimulation. NVC was initiated using electrical field stimulation (EFS; 50 Hz, 0.3 ms
alternating square pulse, 3 s duration) to trigger neuronal action potentials

10, 11

.

Throughout all recordings, brain slices were continually superfused with aerated ACSF
(32-34 °C) containing the thromboxane A2 analog, 9,11 di-dideoxy-11α,9αepoxymethanoprostaglandin F2α (U46619, 100 nM) to induce an intermediate level of
arteriolar tone. Ionomycin (10 µM) and CaCl2 (20 mM) were added to the bath at the end
of each experiment to obtain maximal fluorescence.
Analysis of arteriolar diameter: Intraluminal arteriolar diameter was measured from IRDIC images at 3 evenly spaced points along a 10 µm length of segment exhibiting the
greatest diameter change to EFS. Diameter change is expressed as the percent increase or
decrease from baseline (determined from 10 s prior to EFS and averaged for the 3 points
of measurement). Diameters were measured manually using custom software, SparkAn,
written by Dr. Adrian D. Bonev, at the University of Vermont (Burlington, VT).
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Analysis of endfoot Ca2+: A region of interest (ROI, 1.2 µm x 1.2 µm) was placed within
an endfoot that was either: 1) adjacent to the arteriolar segment used to measure diameter
during EFS or 2) exhibiting spontaneous Ca2+ events in the absence of stimulation.
Spontaneous Ca2+ events were defined by the following criteria: 1) ≥ 30 % increase in
fluorescent intensity for at least 2 consecutive images, and 2) multiple events during a 4
min recording period 11. Endfoot Ca2+ concentrations were estimated using the maximal
fluorescence method 20, 21.
Statistical analysis: Data are expressed as mean ± SEM (n: the number of observations,
N: the number of animals). Student’s two-tailed paired t test was used for comparisons
between two groups.
Reagents: U46619 and ionomycin were obtained from Calbiochem (EMD Millipore,
Chicago, IL).

Fluo-4 AM and pluronic acid were obtained from Invitrogen (Life

Technologies, Eugene, OR). All P2 receptor antagonists were obtained from Tocris
(Bristol, United Kingdom). All other reagents were purchased from Sigma-Aldrich (St.
Louis, MO). The composition of ACSF (in mM) was: 125 NaCl, 3 KCl, 18 NaHCO3,
1.25 NaH2PO4, 1 MgCl2, 2 CaCl2, 5 glucose, and 0.4 ascorbic acid.

Results!
Purinergic receptor inhibition abolishes SAH-induced eHACSs
The role of purinergic signaling in the SAH-induced generation of astrocyte
endfoot high amplitude Ca2+ signals (eHACSs) was explored in brain slices using the
broad-spectrum purinergic receptor antagonist, suramin (100 µM) (Fig. 1). In brain
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slices from control animals, spontaneous Ca2+ signals with amplitudes of less than 500
nM were observed in Fluo-4-loaded endfeet using two-photon imaging. Suramin had no
effect on the amplitude (Fig. 1A, B) or frequency (0.019 ± 0.002 Hz vs 0.018 ± 0.001 Hz,
two-tailed paired t test, p = 0.73) of endfoot Ca2+ signals in control animals. In brain
slices from SAH model animals, endfeet exhibited a mix of “control-like” Ca2+ signals
(amplitudes < 500 nM) and high amplitude (> 500 nM) Ca2+ signals “eHACSs” as
previously described

10, 11

. Suramin treatment of brain slices from SAH animals nearly

abolished eHACSs (Fig. 1B, C), but did not affect lower amplitude “control-like” events
or the overall frequency of spontaneous Ca2+ signals (0.023 ± 0.005 Hz vs 0.025 ± 0.004
Hz, two-tailed paired t test, p = 0.85). In the presence of suramin, the mean amplitude of
endfoot spontaneous Ca2+ signals was comparable between control and SAH groups (Fig.
1D).

These results suggest that purinergic signaling is involved in SAH-induced

eHACSs, but not “control-like” endfoot Ca2+ events.
Suramin restores vasodilatory NVC after SAH
As the emergence of eHACSs has been linked to inversion of NVC after SAH 10,
11

, we examined whether disruption of eHACSs with suramin could restore vasodilatory

NVC in brain slices from SAH animals. In the absence of suramin, generation of
neuronal action potentials using EFS caused parenchymal arteriolar constriction in 100 %
of SAH brain slices (n = 7/7, N = 6) (Fig. 2A). Remarkably, suramin restored arteriolar
dilation to EFS in the majority of brain slices (n = 6/7, N = 6) (Fig. 2B). Suramin,
however, did not alter the amplitude of EFS-evoked endfoot Ca2+ transients (Fig. 2C) or
arteriolar diameter before EFS (6.5 ± 1.1 µm before suramin vs 6.2 ± 1.0 µm after
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suramin, two-tailed paired t test, p = 0.53). These data demonstrate inversion of NVC
after SAH is dependent upon purinergic signaling and the presence of eHACSs in
astrocyte endfeet surrounding parenchymal arterioles.
P2Y receptors mediate SAH-induced eHACSs
Purinergic (P2) receptors are broadly divided into 2 classes: ligand-gated, Ca2+permeable ion channels (i.e., P2X receptors), and metabotropic G-protein coupled (P2Y)
receptors

22

.

P2X receptors and P2Y receptors can be distinguished using α, β

methylene-ATP (α, β-meATP), an ATP analog that rapidly desensitizes P2X, but not P2Y
receptors

23

. To determine if Ca2+ influx through P2X receptors contributes to SAH-

induced eHACSs, spontaneous endfoot Ca2+ signals were recorded in brain slices from
SAH animals before and after a 25 minute application of α, β-meATP (10 µM).
Treatment with α, β-meATP had no effect on the incidence of eHACSs or on the overall
frequency of endfoot Ca2+ signals (Fig. 3A-C), suggesting that P2X receptors are not
involved in the generation of eHACSs after SAH.
To examine the involvement of P2Y receptors in SAH-induced eHACSs, brain
slices from SAH animals were treated with a cocktail of inhibitors targeting Gq-coupled
P2Y receptors.

The components of this mix of P2Y receptor inhibitors included

selective: P2Y1 (MRS 2179, 30 µM), P2Y2 (AR-C 118925XX, 10 µM), P2Y6 (MRS
2578, 30 µM), and P2Y11 (NF 340, 30 µM) receptor antagonists

24-26

. This combination

of P2Y inhibitors blocked eHACSs, but did not alter “control-like” events or the overall
frequency of spontaneous Ca2+ signals (Fig. 3 D-F).

Interestingly, treatment of SAH

brain slices with the PLC inhibitor, U73122 (30 µM, 30 min) abolished both SAH92

induced eHACSs and all “control-like” events (n = 5, N = 3). Spontaneous endfoot Ca2+
signals were also abolished by U73122 in brain slices from un-operated control animals
(n = 7, N = 3), however, the inactive analog, U73343 (30 µM, 30 min), was without effect
(n = 5, N = 4). Together, these data indicate that Gq-coupled P2Y receptor signaling
contributes to the generation of SAH-induced eHACSs and that non-purinergic Gqcoupled receptors mediate “control-like” endfoot Ca2+ signals.
Activation of P2Y receptors in brain slices from control animals mimics SAH
We next sought to determine whether pharmacologic activation of P2Y receptors
could mimic SAH in brain slices from un-operated animals. To obviate the potentially
confounding effects mediated by P2X receptors, brain slices were pre-treated with α, βmeATP (10 µM, 25 min) to desensitize P2X receptors. In the presence of α, β-meATP,
Ca2+ signals in endfeet from control animals were unaltered (i.e., all peaks <500 nM).
However, subsequent treatment of brain slices with the non-hydrolyzable ATP analog,
ATPγS (3 µM), to activate P2Y receptors triggered the emergence of high amplitude Ca2+
signals that were comparable to SAH-induced eHACSs (Fig. 4A-C). These data suggest
that functional P2Y receptors are present on astrocyte endfeet in healthy control animals
and that activating these receptors generates Ca2+ signals resembling SAH-induced
eHACSs. Importantly, this pharmacological approach to activate P2Y receptors also
caused a marked disruption of NVC in brain slices of control animals. In the presence of
α, β-meATP (10 µM, 25 min), focal activation of neurons using EFS caused the
anticipated arteriolar dilation in 100% of brain slices (n = 5/5, N = 4) (Fig. 4D).
However, subsequent treatment with ATPγS (3 µM, 10 min) to activate P2Y receptors,
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caused inversion of NVC (i.e., EFS-induced vasoconstriction) in 2 of 5 brain slices and
attenuated the vasodilatory responses in the other 3 brain slices (Fig. 4D). There was no
effect of ATPγS on the amplitude of the EFS-evoked endfoot Ca2+ transients (Fig. 4E), or
on arteriolar diameter before EFS (6.1 ± 0.9 µm before ATPγS vs 6.2 ± 0.9 µm after
ATPγS, two-tailed paired t test, p = 0.64). These data indicate that P2Y receptormediated Ca2+ elevations in astrocyte endfeet can mimic SAH to disrupt NVC in brain
slices from healthy control animals.
SAH-induced eHACSs occur independent of neurotransmitter release
Neuronal release is one potential source of extracellular purine nucleotides (e.g.
ATP) that could impact endfoot Ca2+ signaling after SAH 12. To assess the contribution
neurotransmitter release on eHACSs, tetrodotoxin (TTX, 3 µM, 20 min), an inhibitor of
voltage-dependent Na+ channels, was used to block neuronal action potentials in brain
slices from SAH animals

10

. Tetrodotoxin had no effect on the occurrence of eHACSs,

the mean amplitude of Ca2+ events, or the frequency of Ca2+ events (Fig. 5A-C),
suggesting that neuronal action potentials are not required for the generation of the P2Y
receptor-mediated eHACSs. These results, however, do not rule out the possibility that
quantal (i.e., action potential-independent) neurotransmitter release or vesicular-mediated
gliotransmitter release underlies the emergence of eHACSs after SAH.
To determine whether vesicular release of purine nucleotides mediates SAHinduced eHACSs, brain slices from SAH animals were treated with bafilomycin A1 (4
µM), a vacuolar H+-ATPase inhibitor (Fig 5 D-G). Bafilomycin depletes both neuronal
and astroglial vesicles of transmitter and has been shown to inhibit Ca2+ signals in the
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fine processes of hippocampal astrocytes 27-29. Brain slices were exposed to bafilomycin
for 4 h at room temperature prior to imaging. Vehicle-treated (DMSO: 1:1000 dilution in
ACSF) brain slices served as time controls for these experiments. Bafilomycin had no
effect on eHACSs, the mean amplitude of events, or frequency of events compared to
time controls (Fig. 5D-F). However, bafilomycin-treated slices failed to respond to EFS
with a rise in endfoot Ca2+ (Fig. 5G) indicating that bafilomycin had successfully
depleted vesicles of neurotransmitter. Together, these results suggest that neither local
neurotransmission nor astroglial vesicular release underlie purinergic receptor activation
leading to SAH-induced eHACSs.

Discussion
This study provides evidence that Gq-coupled P2Y purinergic receptor signaling
underlies the emergence of endfoot high amplitude Ca2+ signals (eHACSs) and the
inversion of NVC in brain slices from SAH animals. The following observations are
consistent with this novel finding: 1) broad-spectrum inhibition of purinergic P2
receptors with suramin blocked eHACSs and restored vasodilatory NVC after SAH; 2)
desensitization of Ca2+-permeable P2X receptors had no effect on the incidence of
eHACSs; 3) SAH-induced eHACSs were abolished using a combination of inhibitors
targeting Gq-coupled P2Y1, P2Y2, P2Y6 and P2Y11 receptors; 4) activation of P2Y
receptors in brain slices from un-operated control animals mimicked SAH by triggering
high-amplitude endfoot Ca2+ events and disrupting NVC. These data identify astrocyte
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purinergic receptor signaling as an important contributor to SAH-induced micro-vascular
dysfunction and impaired NVC.
In brain slices from SAH animals, the emergence of high amplitude spontaneous
Ca2+ signals in astrocyte endfeet has been linked to increased activity of endfoot largeconductance Ca2+-activated (BK) K+ channels, increased perivascular K+ and inversion of
NVC

10, 11

.

Here, we show activation of Gq-coupled P2Y receptors underlies the

emergence of SAH-induced eHACSs. Astrocytes express a variety of P2Y receptor
subtypes that can be activated by multiple ligands found in purine/pyrimidine catabolic
pathways (e.g. ATP, ADP, UTP, UDP)

12, 13

spectrum P2 receptor antagonist, suramin

22

.

As shown in figures 1 and 2, the broad-

, blocked eHACSs and restored NVC after

SAH without affecting normal astrocyte Ca2+ signaling. Aside from acting as a purinergic
antagonist, suramin has been shown to have a number of additional effects, including
interference with receptor/G-protein coupling, inhibition of DNA and RNA polymerases
and inhibition of growth factor binding 22, 30. Suramin has been used for nearly a century
as a treatment for the initial phase of African trypanosomisis, commonly referred to as
sleeping sickness

31

and has been studied as a treatment of high-grade glioma

32

and

prostate cancer 33. Our data using a combination of reagents targeting P2Y1, P2Y2, P2Y6
and P2Y11 receptors (Fig. 3) indicate that the beneficial effects of suramin after SAH (i.e.,
block of eHACSs and rescue of vasodilatory NVC) are due to inhibition of P2 receptors,
rather than off-target effects. Interestingly, Naviaux et al. have recently reported that
suramin, through actions on purinergic signaling, can alleviate autism-like behaviors in a
mouse model of autism spectrum disorder 34. Further, P2Y receptor-mediated disruption
of astrocyte Ca2+ signaling and impaired NVC have been observed in mouse models of
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Alzheimer’s disease

16, 17

. Considering the dire need for better therapeutic options for

patients following aneurysmal SAH

1, 35

, future in vivo studies targeting P2Y receptors

using SAH models are warranted.
P2Y receptors are activated by a number of endogenous ligands, including ATP.
Consistent with a role of extracellular ATP in the generation of SAH-induced eHACSs,
elevated levels of ATP have been reported in CSF after SAH

14, 15

, and we have found

that the non-hydrolyzable ATP analog, ATPγS, mimicked SAH by triggering highamplitude endfoot Ca2+ events and causing inversion of NVC brain slices from control
animals (Fig. 4). A number of sources could potentially contribute to elevated levels of
extracellular ATP in brain parenchyma after SAH. For example, both neurons and
astrocytes are capable of releasing ATP through vesicular-mediated exocytosis

27, 36

.

However, it is unlikely that vesicular-mediated ATP release is involved in the generation
of SAH-induced eHACSs, as neither tetrodotoxin nor bafilomycin impacted these events
(Fig. 5). Astrocytes, considered to be a main source of extracellular ATP in the brain 12,
can also release ATP through connexin-based hemi-channels that are enriched in
perivascular astrocyte
mediated exocytosis

37, 38

39

. ATP can also be released from astrocytes via lysosomal-

. Interestingly, our previous work demonstrated the presence of

lysosomes within hypertrophic endfeet after SAH that could represent a supply of ATP 11.
Extravascular red blood cells (RBCs) represent another potential source of
elevated purine nucleotides in brain parenchyma after SAH. ATP is maintained in
relatively high abundance (> 1 mM) within intact RBCs 40. In addition, autopsy studies
of SAH patients and work using experimental SAH models have both demonstrated
RBCs deposited along the wall of brain parenchymal arterioles following SAH
97

10, 41

.

Considering the relatively small volume of the restricted perivascular space between
astrocyte endfeet and parenchymal arteriolar myocytes, it is conceivable that RBC lysis
could cause relatively high local levels of ATP. However, the appearance of eHACSs
within 24 hrs following the injection of whole blood into the subarachnoid space

11

does

not readily fit with the reported time course (3-7 days) for the lysis of RBCs in CSF after
SAH

42, 43

. Thus, further study will be required to determine the identity and source of

P2Y receptor ligands involved in the generation of SAH-induced eHACSs.
In summary, a growing body of evidence indicates that pathological changes in
astrocyte Ca2+ signaling occur during disease states such as Alzheimer’s disease, epilepsy
and SAH

10, 11, 16, 17, 44

. Further, astrocyte Ca2+ signaling profoundly impacts cerebral

blood flow regulation, including NVC

8, 45, 46

. Here, we expand upon this knowledge by

identifying a causal link between the activity of Gq-coupled P2Y receptors and the
emergence of SAH-induced eHACSs and the inversion of NVC. Our observations are
consistent with previous reports of P2Y receptor-mediated disruption of astrocyte Ca2+
signaling and impaired NVC in mouse models of Alzheimer’s disease

16, 17

. Moving

forward, targeting purinergic signaling in astrocytes may improve cortical blood flow in
patients after SAH and provide additional benefits to individuals with other brain
pathologies.
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Figure 3-1. Inhibition of purinergic signaling with suramin selectively blocks SAHinduced eHACSs
(A) Images of control and SAH parenchymal arterioles with overlapping pseudocolormapped fluorescent Ca2+ levels in surrounding astrocyte endfeet obtained using
simultaneous IR-DIC and 2 photon microscopy (top). Red-dashed lines depict arteriolar
lumen. Scale bar is 10 µm. Traces demonstrating spontaneous fluctuations in intracellular Ca2+ (i.e. spontaneous Ca2+ events) recorded within the regions corresponding to
the black boxes in the above images before and after treatment with suramin (bottom).
The moments in the trace directly beneath the arrows are depicted in the frames above.
These frames capture peak Ca2+ levels during a typical “control-like” event (<500 nM,
left) and during an eHACS (≥500 nM, right) (B) Distribution of all spontaneous Ca2+
event amplitudes recorded in brain slices from control and SAH model animals before
and after treatment with suramin. Note that eHACSs (red dots, peaks ≥500 nM) are
almost completely abolished in SAH brain slices treated with suramin. (C) Summary pie
chart indicating the incidence of endfeet with eHACSs before and after treatment with
suramin. These data only represent endfeet in brain slices from SAH animals. eHACSs
were not observed in brain slices from control animals. (D) Summary data showing the
effect of suramin on the mean amplitudes of all spontaneous endfoot Ca2+ events in brain
slices from control and SAH model animals. Two-tailed paired t test, **p < 0.01.
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Figure 3-2. Blocking eHACSs restores vasodilatory NVC after SAH
(A) Representative traces showing EFS-induced elevation of endfoot Ca2+ (black lines)
and subsequent changes in arteriolar diameter (gray lines). (B) Summary scatter plot
demonstrating EFS-evoked changes in arteriolar diameter before (black triangles) and
after (gray triangles) treatment with suramin. Two-tailed paired t test, **p < 0.01. (C)
Summary data showing EFS-evoked changes in endfoot Ca2+ in SAH brain slices before
and after treatment with suramin.

107

108

Figure 3-3. P2Y receptors mediate SAH-induced eHACSs
(A) Representative trace depicting spontaneous Ca2+ activity recorded from a SAH brain
slice before and after treatment with, α,β-meATP, an ATP analogue that rapidly
desensitizes P2X receptors. (B) Distribution of all spontaneous Ca2+ event amplitudes
recorded in brain slices from SAH animals before and after treatment with α,β-meATP.
eHACSs (black dots) were still present following desensitization of P2X receptors.
Horizontal black lines indicate the mean amplitudes of all events. (C) Summary data
showing the frequency of endfoot Ca2+ events in the presence or absence of α,β-meATP.
(D) Representative trace of spontaneous Ca2+ activity recorded from a SAH brain slice
before and after treatment with a P2Y inhibitor cocktail containing selective P2Y1 (MRS
2179, 30 µM), P2Y2 (AR-C 118925XX, 10 µM), P2Y6 (MRS 2578, 30 µM), and P2Y11
(NF 340, 30 µM) antagonists. (E) Distribution of all spontaneous Ca2+ event amplitudes
recorded from SAH animals before and after treatment with the P2Y inhibitor cocktail.
Note that the P2Y inhibitor cocktail selectively abolished eHACSs (black dots).
Horizontal black lines indicate the mean amplitudes of all events. Two-tailed paired t
test, **p < 0.01. (F) Summary data showing the frequency of spontaneous endfoot Ca2+
events in the presence or absence of the P2Y inhibitor cocktail.
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Figure 3-4. Activation of P2Y receptors in brain slices from control animals mimics
SAH
(A) Representative trace showing the effect of ATPγS, a non-hydrolyzable ATP analog,
on spontaneous Ca2+ activity in a brain slice obtained from a healthy control animal. In
these experiments, α,β-meATP was included in the superfusate to desensitize P2X
receptors. (B) Distribution of all spontaneous Ca2+ event amplitudes recorded in brain
slices from control animals before and after treatment with ATPγS. Note that events
mimicking SAH-induced eHACSs (black dots, peak Ca2+ ≥500 nM) emerged following
treatment with ATPγS. Horizontal black lines indicate the mean amplitudes of all events.
Two-tailed paired t test, n.s. p = 0.05. (C) Summary data showing the frequency of
endfoot Ca2+ events in the presence or absence of ATPγS. Two-tailed paired t test, **p <
0.01.

(D) Summary scatter plot demonstrating EFS-evoked changes in arteriolar

diameter in brain slices from healthy control animals before and after treatment with
ATPγS. Two-tailed paired t test, *p < 0.05. (E) Summary data showing EFS-evoked
changes in endfoot Ca2+ before and after treatment with ATPγS. For studies examining
NVC, α,β-meATP was also included in the slice superfusate.
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Figure 3-5. Local neurotransmission is not involved in the generation of eHACSs
after SAH
(A) Representative trace of spontaneous Ca2+ activity recorded from a SAH brain slice
before and after treatment with tetrodotoxin (TTX), a fast Na+ channel inhibitor that
blocks neuronal action potentials.

(B) Distribution of all spontaneous Ca2+ event

amplitudes recorded in SAH brain slices before and after treatment with TTX. Note that
eHACSs (black dots, peak Ca2+ ≥500 nM) are still present following treatment with TTX.
Horizontal black lines indicate the mean amplitudes of all events. (C) Summary data
showing the frequency of endfoot Ca2+ events in the presence or absence of TTX. (D)
Representative traces of spontaneous Ca2+ activity recorded from SAH brain slices from
either the vehicle-treated time control (left), or bafilomycin A1-treated (right) groups.
Bafilomycin A1 depletes vesicles of neurotransmitter by inhibiting the vacuolar H+ATPase. (E) Distribution of all spontaneous Ca2+ event amplitudes recorded in SAH
brain slices from the vehicle-treated time control (- bafilomycin), or bafilomycin A1treated groups. Note eHACSs were not abolished in bafilomycin-treated SAH brain
slices. (F) Summary data showing the frequency of endfoot Ca2+ events in vehicletreated time control, or bafilomycin A1-treated SAH brain slices. (G) Summary data
showing EFS-evoked changes in endfoot Ca2+ recorded from vehicle-treated time control,
or bafilomycin A1-treated SAH brain slices. Note EFS failed to elevate endfoot Ca2+ in
bafilomycin A1-treated SAH brain slices. Two-tailed paired t test, **p < 0.01, n.s. p >
0.05.
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Chapter 4: Discussion and Future Directions
The studies included in this dissertation were designed to address two specific
aims: (1) to determine whether altered astrocyte Ca2+ signaling, in the form of eHACSs,
is causally linked to the inversion of neurovascular coupling after SAH and (2) to
elucidate the cellular basis underlying the generation of eHACSs. Our data provide
substantial evidence that SAH-induced eHACSs cause a pathological shift in
neurovascular coupling from vasodilation to vasoconstriction.

Both phenomena,

eHACSs and inversion of neurovascular coupling, followed a similar time-dependent
pattern of development.

Further, depleting ER Ca2+ stores or selectively blocking

eHACSs restored vasodilatory responses in SAH brain slices. Together, these data
indicate that eHACSs drive inversion of neurovascular coupling after SAH. Moreover,
our results identify perivascular astrocytes as a contributing element to the parenchymal
arteriolar dysfunction and impaired cerebral hemodynamics commonly observed
following aneurysmal SAH.
Our data provide evidence that purinergic signaling via Gq-coupled P2Y receptors
underlies the generation of eHACSs after SAH. Treating SAH brain slices with the
broad-spectrum purinergic receptor antagonist, suramin, selectively blocked eHACSs and
restored vasodilatory neurovascular coupling.

The fact that a purinergic signaling

pathway triggers a pathological change in astrocyte Ca2+ signaling after SAH is not
surprising. Extracellular purine nucleotides, such as ATP, are commonly elevated in the
brain following injury (Franke et al., 2012). Kasseckert et al. (2013) measured a 400-fold
increase in the concentration of ATP in the cerebrospinal fluid (CSF) of SAH patients
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compared to non-SAH controls.

Importantly, the investigators found that exposing

cultured human astrocytes to the bloody CSF triggered a steep elevation of intra-cellular
Ca2+ that was prevented by either suramin, or the IP3R antagonist, xestospongin D. In the
live rodent, evidence suggests that arterial pulsation drives the flow of CSF into the brain,
alongside parenchymal arterioles in between astrocyte endfeet and vascular smooth
muscle (Iliff et al., 2012; Iliff et al., 2013). This flow pattern would be expected to
deliver CSF with elevated ATP levels directly into the perivascular space where it could
alter endfoot Ca2+ dynamics leading to the emergence of eHACSs.
The above description details one way in which SAH could trigger P2Y receptormediated eHACSs.

However, there are unresolved issues that argue against this

possibility. Mainly, in the acute brain slice preparation the flow of CSF has typically
been stopped for hours before imaging. Even if ATP levels within the perivascular space
were elevated at the time the animal was euthanized, ectonucleotidases would likely
degrade ATP prior to the start of the experiment. Under physiologic conditions, the
concentration of extracellular purine nucleotides is regulated by the activity of
ectonucleoside triphosphate diphosphohydrolases (E-NTPDases).

Astrocytes express

several members of the E-NTPDase family, with E-NTPDase 2, being the enzyme most
responsible for ATPase activity (Wink et al., 2006). Astrocytes also express ecto-5’nucleotidase/CD73 allowing them to convert AMP to adenosine (Wink et al., 2003).
Thus, the full compliment of enzymes expressed by astrocytes would allow them to fully
degrade ATP trapped within the perivascular space after SAH. It is important to mention
here that blood vessels also express E-NTPDases, with E-NTPDase 1 being the
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predominant enzyme in the brain vasculature (Braun et al., 2000). Thus, CSF-derived
ATP seems unlikely to trigger eHACSs in the ex vivo brain slice preparation.
The multiple reports linking SAH to increased levels of ATP in the CSF have
suggested that lysed erythrocytes (i.e., red blood cells) are the source of ATP after SAH
(Macdonald et al., 2001; Yin et al., 2002; Kasseckert et al., 2013). Given the flow of
CSF into the brain parenchyma, one would expect extravasated red blood cells to invade
the brain cortex alongside parenchymal arterioles. In fact, the accumulation of
extravascular red blood cells in human SAH patients was already described over 50 years
ago (Crompton, 1964). Using the double injection cisterna magna SAH model, Koide et
al. (2012) observed red blood cells adjacent to the parenchymal arteriolar wall, up to 1
mm from the cortical surface within 10 min of SAH. Extravascular red blood cells were
also observed along parenchymal arterioles up to 7 d post-SAH using the acute brain slice
preparation (Pappas et al., 2015). It could be argued that the slow and gradual breakdown
of perivascular red blood cells after SAH leads to a localized elevation of ATP
independent of the ATP levels in circulating CSF. Thus, the presence extravascular
debris may be linked to the emergence of P2Y receptor-mediated eHACSs after SAH.
Careful studies must be designed to determine whether breakdown of extravascular red
blood cells generates SAH-induced eHACSs. A simple first step would be to inject a
comparable volume of hemolysate into the cisterna magna of anesthetized animals and
determine whether their brain slices exhibit eHACSs or inversion of neurovascular
coupling at 2 d post-SAH.

Lysing the red blood cells before delivery into the

subarachnoid space, would remove the possibility of the cells accumulating along the
arterioles and gradually releasing their contents into the extracellular milieu. Although
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the injected hemolysate would contain high levels of ATP, endogenous ectonucleotidases
would be expected to degrade the nucleotides relatively quickly.
Another possibility is that reactive gliosis is involved in the release of
extracellular purine nucleotides after SAH. Inflammatory perturbations to the CNS,
including SAH, cause nearby microglia to shift from a dormant state to an activated state
(Murakami et al., 2011; Plog et al., 2014). In a recent study, Pascual et al. (2012)
demonstrated that the activation of brain microglia resulted in the release of ATP onto
nearby astrocytes.

Importantly, the resultant activation of astrocyte P2Y1 receptors

triggered additional ATP release from the astrocytes, thereby causing an amplification of
the purinergic signal. In addition to stimulating the release of gliotransmitters, activation
of P2Y1 receptors has been linked to the development of reactive astrogliosis (Franke et
al., 2001). There is strong evidence, such as increased expression of glial fibrillary acidic
protein (GFAP) and S100β, that reactive astrogliosis occurs following SAH (Yokota et
al., 1994; Murakami et al., 2011). Presently, we demonstrate a hypertrophic morphology
of astrocyte endfeet, a clear indication of reactive astrogliosis, in tissue obtained from 2 d
SAH animals (see Fig. 2-5). Our time course data show a gradual emergence of endfeet
exhibiting eHACSs, reaching a peak at 2 d post-SAH, and then slowly declining at later
time-points (see Fig. 2-1). The prevailing thought is that the inflammatory component to
reactive gliosis occurs early following injury (between 0 and 7 d post-insult) and
subsequently shifts to a phase of cell proliferation and tissue remodeling (Burda and
Sofroniew, 2014). Interestingly, the time course in which the inflammatory response is
suggested to occur appears to coincide with the emergence of eHACSs and development
of inversion of neurovascular coupling. Future studies will be necessary to determine the
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relationship

between

these

phenomena.

For

example,

one

could

use

immunohistochemistry to determine if SAH-induced activated microglia are in close
enough proximity to initiate ATP release from perivascular astrocytes. To date, the vast
majority of work suggests that astrocyte ATP release mechanisms involve either: (1)
Ca2+-dependent exocytosis of ATP-containing vesicles (Montana et al., 2006; Bowser
and Khakh, 2007), (2) ATP efflux through plasmalemmal hemichannels formed by
connexins and pannexins (Kang et al., 2008), or (3) ATP release via lysosomes (Zhang et
al., 2007). Functional studies targeting the above mechanisms could also be used to
determine whether eHACSs after SAH are the result of a paracrine/autocrine astrocyte
purinergic signaling pathway.
Our data demonstrate that suramin selectively blocked eHACSs and restored
vasodilatory neurovascular coupling after SAH. Although suramin is recognized as a
broad-spectrum purinergic (P2) receptor antagonist (Ralevic and Burnstock, 1998), it has
also been suggested to have many off-target effects including: disruption of growth factor
receptor signaling (Coffey et al., 1987), uncoupling of G-protein coupled receptors
(Beindl et al., 1996), and activation of skeletal muscle ryanodine receptors (Hohenegger
et al., 1996). Despite the widespread actions of suramin, the positive effects we observed
in SAH brain slices are most likely due to block of P2Y receptor signaling. Most
importantly, we observed a similar block of SAH-induced eHACSs in brain slices treated
with a cocktail of inhibitors targeting Gq-coupled P2Y receptors (Fig. 3-3). These data
argue against potential off-target effects, such as disruption of growth factor receptor
signaling. Currently, there is a lack of evidence supporting functional expression of
ryanodine receptors (i.e., ER Ca2+ release channels) in astrocytes in situ (Straub et al.,
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2006). If suramin were activating astrocyte ryanodine receptors, then one would predict
that suramin would cause an increased amplitude and frequency of endfoot Ca2+ events.
Instead, we observed a selective blockade of SAH-induced eHACSs and no change in
Ca2+ event frequency in control or SAH brain slices following treatment with suramin
(Fig. 3-1). Our results also argue against an uncoupling of G-protein coupled receptors.
The endfoot Ca2+ transients evoked by EFS are sensitive to phospholipase C inhibition
indicating that Gq-coupled receptors mediate neuronal activity-dependent elevation of
endfoot Ca2+ (Straub et al., 2006). We observed no change in the amplitude of the EFSevoked endfoot Ca2+ transients in brain slices treated with suramin (Fig. 3-2). Further,
the vasoconstrictor, U46619, is a Gq-coupled receptor agonist.

If suramin were

uncoupling G-protein coupled receptors, then one would predict that suramin would
abolish arteriolar tone. However, we observed no change in parenchymal arteriolar
diameter following treatment with suramin. Thus, despite suramin’s potential off-target
effects, the most likely explanation for our results is that suramin is disrupting SAHinduced eHACSs by blocking astrocyte P2Y receptors.
Suramin is a well-tolerated FDA-approved drug that has been used previously to
treat high-grade glioma (Grossman et al., 2001). This is significant as it identifies a
signaling pathway that could be targeted therapeutically in the management of SAH
patients.

Current therapeutic options are limited and often have poor efficacy.

Experimental evidence using a canine SAH model has already provided evidence that in
vivo treatment with suramin reduces the severity of SAH-induced vasospasm; although
the investigators claim the effects were due to inhibition of tyrosine kinase activity
(Kimura et al., 2002). Future studies will be necessary to determine (1) if inversion of
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neurovascular coupling occurs in SAH animals in vivo, and (2) if suramin can restore or
improve vasodilatory neurovascular coupling after SAH.
Our data provide strong evidence that SAH-induced eHACSs are mediated by the
activity of Gq-coupled P2Y receptors. Astrocytes express most P2Y receptor subtypes
and immunohistochemical examination has already revealed expression of the Gqcoupled receptors P2Y1, P2Y2 and P2Y4 on perivascular endfeet (Franke et al., 2012;
Simard et al., 2013). There have been no studies examining the localization of other
astrocyte Gq-coupled P2Y receptors in relation to the intra-cerebral vasculature. It is
possible that multiple P2Y receptor subtypes are responsible for the generation of
eHACSs after SAH. P2Y receptors can exist as homodimers or heterodimers with other
P2 receptors, or P1 (i.e., adenosine) receptors (Tonazzini et al., 2008; Koles et al., 2011).
Further, if extracellular purine and/or pyrimidine nucleotides are driving the generation of
eHACSs after SAH, then it stands to reason that one P2Y receptor could be involved in
triggering a Ca2+ event in response to ATP, while another receptor responds to ATP’s
degradation product, ADP. Accordingly, the same would be expected for the pyrimidines
UTP and UDP. Thus, it seems that a broad-spectrum purinergic receptor antagonist, such
as suramin, would be the most useful approach to block P2Y receptor-mediated eHACSs
after SAH.

Future studies using a combination of qPCR/western blotting and

immunohistochemistry could be useful to determine if SAH leads to an increased
expression of Gq-coupled P2Y receptors in perivascular astrocytes. This may aid in
narrowing down the exact mechanism by which extracellular purine and/or pyrimidine
nucleotides trigger eHACSs.
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To conclude, the studies presented in this dissertation demonstrate that the
inversion of neurovascular coupling after SAH is due to a pathological change in
astrocyte endfoot Ca2+ signaling (i.e., eHACSs). Our results provide clear evidence that
perivascular astrocytes play a pivotal role in mediating SAH-induced vascular
dysfunction.

Importantly, our data indicate a role for extracellular purine and/or

pyrimidine nucleotides in the generation of eHACSs after SAH. We report that inhibition
of Gq-coupled P2Y receptors selectively blocked eHACSs and restored vasodilatory
neurovascular coupling in brain slices obtained from SAH animals. Moving forward, it
will be important to determine the link between SAH and enhanced purinergic signaling.
Further, it will be necessary to consider the role of perivascular astrocytes in the
development of neurological deficits following aneurysmal SAH.
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